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Abstract 
Chapter 1: Heterobicyclo[2.1.0]pentanes are unique scaffolds that posses interesting 
reactivity.  A review of both the synthesis and chemistry pertaining to these compounds 
is covered. 
X
X = O, N, S
 
Chapter 2: Epoxidation of highly strained cyclobutenes followed by thermal 
rearrangement provides a new entry into oxepine-containing bicyclo[5.3.0] ring systems.  
In contrast to the rearrangement of the corresponding cyclopropanated systems, the 
strained epoxides in this study are believed to fragment through two competing pathways 
leading to a mixture of diastereomeric 5-7 ring systems. 
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Chapter 3: Cyclopropanation of highly strained cyclobutenes followed by thermal 
rearrangement provides rapid entry into bicyclo[5.3.0] decane ring systems. 
Rearrangement of these systems is selective and allows for the synthesis of multiple 
guaiane sesquiterpenes from a common intermediate.  Specifically the synthesis of 
bulnesol, 11-hydroxypogostol, hanamyol, pleocarpenene, and pleocarpenone will be 
highlighted. 
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TIPS   triisopropylsilyl 
THF   tetrahydrofuran 
TLC   thin layer chromatography 
Ts   p-toluenesulfonyl 
TsCl   p-toluenesulfonyl chloride 
TsOH   p-toluenesulfonic acid 
wt.   weight 
 
 1 
Chapter 1:  Heterobicyclo[2.1.0]pentanes: A review of their synthesis 
and chemistry 
1.1 Introduction 
Strained heterocycles offer a unique entry into a variety of heterocyclic compounds 
that may otherwise be difficult to access.  This review will focus on the synthesis and 
chemistry of heterobicyclo[2.1.0] pentanes of the general structure 1.1.   The formation of 
5-oxabicyclopentanes, 5-azabicyclopentanes, and 5-thiabicyclo[2.1.0]pentanes (Figure 
1.1) will be explored, as well as their fragmentations to afford seven and eight membered 
heterocycles.1  While there exists some chemical methods to fragment these systems, this 
review will focus on thermal and photochemical induced rearrangements.2   
HN
5-azabicyclo[2.1.0]pentane
S
5-thiabicyclo[2.1.0]pentane
O
5-oxabicyclo[2.1.0]pentane
X
1.1
Figure 1.1:  Heterobicyclo[2.1.0]pentanes
                                                
(1) For a review on the synthesis of seven membered heterocycles see Bremner, J. B.; Samosorn, S. 
Progress in Heterocyclic Chemistry 2008, 19, 437-464.  For a review on the synthesis of eight membered 
heterocycles see Newkome, G. R. Progress in Heterocyclic Chemistry 2008, 19, 465-483.    
(2) For examples of chemically induced fragmentation/rearrangement see Krow, G. R.; Lester, W. S.; Liu, 
N.; Yuan, J.; Hiller, A.; Duo, J.; Herzon, S. B.; Nguyen, Y.; Cannon, K. J. Org. Chem. 2001, 66, 1811-
1817.  
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1.2 Synthesis and chemistry of 5-oxabicyclo[2.1.0]pentanes 
Applications toward the synthesis of seven membered rings 
Tsuchiya pioneered most of the work covered in this review and has shown the 
utility of oxabicyclo[2.1.0]pentanes in the synthesis of seven membered oxepines.  Using 
Tsuchiya’s methodology, 1,4-oxazepine 1.3 can be generated from thermal isomerization 
of hetero-tricycloheptane 1.2 in excellent yield (eq. 1.1).3   
N
O
O
N
CO2Me
CO2Me
toluene
reflux
95%
1.2 1.3
(eq. 1.1)
 
Epoxide 1.2 can be accessed in three steps from pyridine (1.4).  Treatment of 1.4 with 
sodium borohydride in the presence of methyl chloroformate affords dihydropyridine 1.5 
in 65% yield.  Isomerization of 1.5 under photochemical conditions produces cyclobutene 
1.6 in 85% yield (eq. 1.2).4     
N
1.4
NaBH4
ClCO2CH3
MeOH, -70 oC
65%
N
CO2Me
1.5
h!
CH2Cl2
85%
N
CO2Me
1.6
(eq. 1.2)
 
Tsuchiya employed m-chloroperoxybenzoic acid (m-CPBA) to epoxidize cyclobutene 1.6 
in 90% yield (eq. 1.3).3  While the authors do not verify the stereochemistry of epoxide 
1.2, they suggest the anti conformer.5 
                                                
(3) Kurita, J.; Iwata, K.; Hasebe, M.; Tsuchiya, T. J. Chem. Soc. Chem. Commun. 1983, 941. 
(4) Fowler, F. W. J. Org. Chem. 1972, 37, 1321. 
(5) Kurita, J.; Yoneda, T.; Kakusawa, N.; Tsuchiya, T. Heterocycles 1987, 26, 3085. 
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N
CO2Me
1.6
m-CPBA
90 % N
O
CO2Me
1.2
(eq. 1.3)
N
O
CO2Me
=
anti-1.2  
According to the authors, fragmentation of 1.2 may proceed via diradical intermediate 1.7 
(Figure 1.2), which agrees with observations made for the fragmentation of 
bicyclo[2.1.0]pentanes.6 However, the presence of oxygen in the 7 position may allow for 
the formation of ionic intermediate 1.8 (Figure 1.2).3  
N
O
N
O
CO2MeCO2Me
1.7 1.8
Figure 1.2:  Possible fragmentation intermediates
 
 Tsuchiya expanded the scope of this fragmentation by synthesizing substituted 1,4 
oxazepines.  Heating epoxides 1.9 in refluxing toluene afforded the ring-expanded 
oxazepines 1.10 in 72-95% yield (Figure 1.3).7  Under these conditions the fragmentation 
proved compatible with alkyl and aryl substitution. 
                                                
(6) Steel, C.; Zand, R.; Hurwitz, P.; Cohen, S. G. J. Am. Chem. Soc. 1964, 86, 679. 
(7) Kurita, J.; Iwata, K.; Sakai, H.; Tsuchiya, T. Chem. Pharm. Bull. 1985, 33, 4572. 
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R1 R2
!
O
NX
R1
R2
R1 R2 X
H
H
Me
H
Me
Me
Ph
H
H
H
Ph
Ph
H
H
CO2Me
CO2CH2Ph
CO2CH2Ph
CO2CH2Ph
CO2CH2Ph
CO2Me
CO2Me
yield (%)
95
88
76
91
72
78
87
1.9 1.10
Figure 1.3:  Substrate scope for the synthesis of substituted 1,4-oxazepines
 
The scope of this thermal fragmentation was expanded to include 1,4-oxazepin-5-
ones.  Heating 3,7-diaza-4-oxotricyclo[4.1.0.02,5]heptanes 1.11 to 140 oC in 
dichlorobenzene afforded seven membered products 1.12 in 70-90 % yield (eq. 1.4).5  
These experiments highlight the compatibility of β-lactams and secondary amides with 
the thermal fragmentation.      
NH
O
OR
2
R1
R1 = H, R2 = H
R1 = Me, R2 = H
R1 = H, R2 = Me
140 oC
dichlorobenzene
70-90%
NH
O
O
R2
R1
1.11 1.12
(eq. 1.4)
 
 Tsuchiya investigated photochemical fragmentations of 5-oxabicylcopentates.  
Specifically these experiments were performed with epoxides 1.14, which were 
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synthesized from compounds 1.13 by dehydrogenation with tert-butyl hypochlorite and 
DBU (eq. 1.5).8   
N
O
R1
R2
Ph
R1 = R2 = H
R1 = Me, R2 = H
R1 = R2 = Me
1.14
NH
O
R1
R2
Ph
t-BuOCl
DBU, DMF
70-85%
1.13
(eq. 1.5)
 
Irradiation of epoxide compounds 1.14 in acetonitrile produced fully unsaturated 1,4-
oxazepines 1.15 in 90-95% yield (eq. 1.6). 
N
O
R1
R2
Ph
h!
MeCN
90-95%
O
N
Ph
R1
R2
1.14 1.15
(eq. 1.6)
 
Mechanistically, this isomerization proceeds by an electrocyclic ring opening to afford 
oxa-norcaradienes 1.16.  Compound 1.16 can undergo Cope rearrangement to afford 
observed products 1.15.  The authors suggest this mechanism as opposed to initial 
cleavage of the epoxide due to the observation that saturated epoxides 1.13 were inert 
under photochemical conditions.  Interestingly oxazepines 1.15 were shown to rearrange 
under thermal conditions through initial reversion to oxa-norcaradiene 1.16.  When R2 is 
a methyl group, 1.16 undergoes a walk rearrangement to afford another oxa-norcaradiene 
                                                
(8) Kurita, J.; Iwata, K.; Tsuchiya, T. Chem. Pharm. Bull. 1987, 35, 3166. 
 6 
(1.17).9  Cope rearrangement of 1.17 affords 1,3-oxazepines 1.18.  When R2 is hydrogen, 
pyridines 1.19 are observed most likely via C-O bond fission and hydrogen atom transfer 
(Scheme 1.1).    
N
O
R1
R2
Ph
h! h!
O
N
Ph
R1
R2
"
N
O
Ph
R1
R2
R2 = MeR
2 = H
N
PhR1
R2
O
N
PhR1
HO
1.151.16
1.17
O
N
Ph
Me
Me
1.18
1.14
1.19
Scheme 1.1: Photochemical rearrangement of compounds 1.14 and 
thermal rearrangements of compounds 1.15
"
"
"
 
Applications toward the synthesis of eight membered rings 
 While the above examples showcased the expansion of  strained “3-4-4” 
heterocycles to afford seven membered heterocycles, Tsuchiya applied the same concept 
of expanding strained heterocycles to “3-4-5” systems in attempts to synthesize eight 
membered rings.  One of these “3-4-5” heterocycles can be synthesized beginning with 
diazepines 1.20.  Irradiation of 1.20 in acetonitrile induces electrocyclization to afford 
                                                
(9) For examples of walk rearrangements of norcaradienes containing oxiranes see Spence, G. G.; Taylor, 
E. C.; Buchardt, O. Chem. Rev. 1970, 70, 231. 
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cyclobutenes 1.21.10  Oxidation of cyclobutenes 1.21 with m-CPBA generates epoxides 
1.22 in good yield (eq. 1.7).11 
N
N
CO2Et
Cbz h!
N
N
R R
Cbz
CO2Et
1.20 1.21
R = H, Me
m-CPBA
N
N
R
Cbz
CO2Et
O
1.22
(eq. 1.7)
 
Hydrogenolysis over palladium on carbon followed by dehydrogenation using tert-butyl 
hypochlorite and DBU provides substrate 1.23 (eq. 1.8). 
N
N Cbz
CO2Et
O
1.22
N
N
CO2Et
O
R
1.23
1) H2, Pd-C
2) t-BuOCl, DBU
R
(eq. 1.8)
 
Surprisingly, irradiation of epoxide 1.23 did not afford the expected eight membered ring 
products 1.24.  Instead cyclopropyl aldehydes 1.25 were isolated as the sole products in 
30-40% yields (Scheme 1.2).11 
                                                
(10) Tsuchiya, T.; Snieckus, V. Can. J. Chem. 1975, 53, 519. 
(11) Kurita, J.; Sakai, H.; Tsuchiya, T. J. Am. Chem. Soc., Chem. Commun. 1985, 24, 1769.   
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N
N
CO2Et
O
h!
N
N
CO2Et
R
OHC
R
O N
N
CO2Me
R
30-40%
1.23 1.25
h!
1.24
Scheme 1.2:  Irradiation of epoxides 1.23
 
Photo-induced ring contraction of 1.23 is believed to proceed through initial homolytic 
N-N bond cleavage to generate diradical intermediate 1.26.  Synchronous cleavage of the 
cyclobutane and epoxide would afford enol diradical 1.27, which undergoes ring 
contraction to generate the observed cyclopropyl aldehydes 1.25 (Scheme 1.3).  
N
NO
R
CO2Et
N
NO
R
CO2Et
N
N
CO2Me
O
R
N
N
CO2Me
R
H
O
1.23 1.26 1.27
1.25
Scheme 1.3:  Proposed mechanism of photo-induced ring contraction of epoxide 1.23
 
Under conventional thermal conditions (refluxing solvent at 160 oC) epoxides 
1.23 were unreactive.  However, investigations using flash vacuum pyrolysis (f.v.p.) with 
 9 
epoxides 1.23 gave interesting results.  Once again rearrangement did not provide the 
expected eight membered ring products 1.24, but instead afforded pyrroles 1.28 (Scheme 
1.4).12   
N
N
CO2Et
O
R f.v.p.
390 oC
3 X 10-5 mmHg N
HN CO2Et
R
OHC
1.23 1.28
O N
N
CO2Me
R
1.24
Scheme 1.4:  Thermal isomerization of epoxide 1.23
 
The mechanistic rationale for generation of pyrroles 1.28 begins with initial formation of 
expected oxadiazocine 1.30 via diradical 1.29.  Oxadiazocine 1.30 could undergo an 
electrocyclic rearrangement to afford epoxide 1.31, which in turn could rearrange to 
afford epoxide 1.32.  Subsequent ring contraction and epoxide opening would produce 
pyrrolinium imide 1.33.  This imide would then undergo aromatization to afford the 
observed products 1.28 (Scheme 1.5).12  
                                                
(12) Kurita, J.; Sakai, H.; Tsuchiya, T. Heterocycles 1987, 26, 2861. 
 10 
N
N
CO2Et
O
R
N
N
CO2Et
O
R
N N
O
R
EtO2C
N N
O R
EtO2C
N N
R
EtO2C
O
N
R
OHC
H
N
EtO2C
N
HN CO2Et
R
OHC
1.23 1.29 1.30 1.31
1.321.331.28
!
Scheme 1.5:  Proposed mechanism for thermal isomerization of epoxides 1.23
 
Support for this mechanism was obtained by isolation of both imide 1.35 and pyrrole 1.36 
from the thermal rearrangement of epoxide 1.34 (eq. 1.9).  Heating imide 1.35 in xylene 
at 140 oC provided pyrrole 1.36 in 85% yield (eq. 1.10).12 
N
N
CO2Et
O NOHC
Me
N
EtO2C
N
HN CO2Et
Me
1.34 1.35 1.36
Me
Me
Me Me
CHO+
f.v.p.
390 oC
3 X 10-5 mmHg
(eq. 1.9)
NOHC
Me
N
EtO2C
N
HN CO2Et
Me
1.35 1.36
Me Me
CHO
140 oC
xylenes
85%
(eq. 1.10)
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The fragmentation of “3-4-5” ring systems containing other 5 membered 
heterocycles also provided interesting rearrangements.  Electrocyclic rearrangement of 
oxepines 1.37 provides cyclobutenes 1.38, which can then undergo oxidation with m-
CPBA to generate epoxides 1.39 (eq. 1.11).13 
O
OR
2
R1
1.39
O
R2
R1
h!
70-80%
O
R2
R1
1.381.37
m-CPBA
80%
(eq. 1.11)
R1 = R2 = H
R1 = H, R2 = Me
R1 = R2 = Me  
Subjecting epoxides 1.39 to f.v.p. at 550 oC provided the expected 1,4-benzodioxocines 
1.40 along with benzopyrans 1.41 and 1.42 (eq. 1.12). This synthetic approach provided 
the first known examples of 1,4-benzodioxocines.13 
O
OR
2
R1
f.v.p.
550 oC
O
O +
O
R1
R2
R1
R2
O R1
R2
+
15-25% 10-25% 10-20%
1.39 1.40 1.41 1.42
(eq. 1.12)
 
The authors suggest that formation of 1.40 occurs via initial C-C bond cleavage in the 
oxirane ring of 1.39 to provide either diradical or ionic intermediates similar to the 
fragmentation of “3-4-4” systems (see Figure 1.2). In a separate experiment the authors 
confirmed that pyrans 1.41 and 1.42 are derived from benzodioxocines 1.40.  Subjecting 
benzodioxocines 1.40 to the same reaction conditions affords pyrans 1.41 and 1.42 in 30-
                                                
(13) Kurita, J.; Yamada, S.; Sakai, H.; Tsuchiya, T. J. Chem Soc., Chem. Commun. 1985, 24, 1254. 
 12 
40% yields.  Mechanistically, pyrans 1.41 and 1.42 may arise from a [1,3]-sigmatropic 
rearrangement of 1.40 to afford aldehydes 1.43.  These aldehydes can then undergo 
decarbonylation to provide pyrans 1.41 and 1.42 (Scheme 1.6).   
O
O
R1
R2
O R1
R2 CHO
1.40
[1,3]
1.43
decarbonylation
O R1
R2
O R1
R2
+
1.41 1.42
Scmeme 1.6: Proposed mechanism for the formation of pyrans 1.41 and 1.42
 
 Tsuchiya also investigated a “3-4-5” ring substrate in which the oxygen in the five 
membered ring is replaced with nitrogen.  Epoxides 1.44, generated from the 
corresponding cyclobutenes, were unreactive when heated at 180 oC in dichlorobenzene.  
However, using f.v.p. at 530 oC produced the expected 4,1-benzoxazocines 1.45 together 
with furoindoles 1.46 and quinoline 1.47 (Figure 1.4).14  
                                                
(14) Kurita, J.; Kikuchi, K.; Aruga, T.; Tsuchiya, T. Heterocycles 1992, 34, 685. 
 13 
N
X
O f.v.p.
530 oC
3 X 10-5 mmHg
N
X
O +
N
X
O +
N
X yields (%)
COMe 21 39 12
COPh 18 28 13
CHO 36 30 15
CO2Me 10 43 19
Me 0 0 30
H 0 0 trace
1.44 1.45 1.46 1.47
Figure 1.4: Thermal fragmentation of epoxide 1.44
 
The authors suggest that formation of 4,1-benzoxazocines 1.45 occurs via homolytic 
cleavage of the oxirane C-C bond to generate diradical intermediates similar to 
intermediate 1.7 in see Figure 1.2.  Quinoline 1.47 was proven to derive from 4,1-
benzoxazocines 1.45 by subjecting the eight membered products to f.v.p. conditions.  The 
formation of quinoline 1.47 is suggested to proceed through a [1,3]-sigmatropic 
rearrangement similar to the one proposed for the benzofuran analogs (see Scheme 1.6).  
This rearrangement provides aldehyde intermediates 1.48 which can undergo 
aromatization to generate quinoline 1.47 (Scheme 1.7).14 
XN
O
N
X
H CHO
1.45
[1,3]
1.48
aromatization
N
1.47
Scmeme 1.7: Proposed mechanism for the formation of quinoline 1.47
 
 14 
Formation of furoindoles 1.46 is believed to involve rearrangement of diradical 
intermediate 1.49.  Rather than undergoing C-C bond cleavage to generate the eight 
membered ring (1.45), diradical 1.49 can undergo C-N bond cleavage to generate 
diradical 1.50.  After a bond rotation, diradical 1.50 would have proper alignment for 
bond formation and generation of furoindoles 1.46 (Scheme 1.8).   
N
X
O
NX
O
N
X
O
1.49 1.50 1.46
Scheme 1.8:  Proposed fragmentation pathway to generate furoindoles 1.46
 
 
Fragmentation of indene derived epoxides also showed evidence of radical 
rearrangements.  Under f.v.p. conditions at 530 oC epoxides 1.51 generated benzoxocins 
1.52 in small amounts together with three different indenofurans (1.53-1.55) (eq. 1.13).15  
O
R2
R1
R1 = H, R2 = H
R1 = Me, R2 = H
R1 = H, R2 = Me
f.v.p.
530 oC O
R2
R1
+
O
R1
R2
+
O
R1 R
2
+
O
R1
R2
50-60%
10-15%
1.51 1.52
1.53 1.54 1.55
(eq. 1.13)
 
Pathways leading to the formation of benzoxocins 1.52 and indenofurans 1.53 are 
suggested to arise from cleavage of the oxirane C-C bond to generate diradical 1.56.  
                                                
(15) Kurita, J.; Aruga, T.; Tsuchiya, T. Heterocycles 1990, 31, 1769. 
 15 
Reacting from diradical 1.56, cleavage of the central bicyclooctane bond would afford 
benzoxocins 1.52.  Competing bond cleavage to generate benzyl diradical 1.57 provides a 
route to indenofurans 1.53 that involves bond rotation and C-C bond formation (Scheme 
1.9).15 
R2
R1
O
O
R2
R1
R2
R1
O
R1
O
R2
O
R1
R2
Scheme 1.9: Pathways leading to 1.52 and 1.53
1.52
1.531.56 1.57 1.58
 
Alternate cleavage of epoxides 1.51 via the C-O bond, leading to diradicals 1.59 and 
1.60, provides access to indenofurans 1.54 and 1.55.  After C-O bond cleavage, diradicals 
1.59 and 1.60 can undergo rearrangement to open the cyclobutane and afford diradicals 
1.61 and 1.62.  Quenching of these diradicals through bond formation generates the 
observed indenofurans 1.54 and 1.55 (Scheme 1.10).15   
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O
R2
R1
O
R2
R1
R2
R1
O O
R1
R2
R2
R1 O OR1
R2
1.59
1.60
1.61
1.62
1.55
1.54
Scheme 1.10: Pathways leading to 1.54 and 1.55
 
1.3 Synthesis and chemistry of 5-azabicyclo[2.1.0]pentanes 
Applications toward the synthesis of seven membered rings 
Coinciding with his investigation of 5-oxabicyclo[2.1.0]pentanes, Tsuchiya also 
explored the synthesis and utility of 5-azabicyclo[2.1.0]pentanes.  In all cases, aziridines 
of the “3-4-4” systems showed the same fragmentation behavior as the corresponding 
epoxides.  Tsuchiya was able to prepare aziridines 1.643 from cyclobutenes 1.63 by using 
ethoxycarbonylnitrene generated from N-ethoxycarbonyl-p-nitrobenzenesulfonamide.16  
Fragmentation of aziridines 1.64 in refluxing xylene proceeds to afford diazepines 1.65 in 
moderate yields (Figure 1.5).7  As in the case of the epoxides, the authors initially 
suggest that fragmentation of aziridines 1.64 may involve diradical or ionic intermediates 
similar to those shown in Figure 1.2.  
                                                
(16) Lwowski, W.; Maricich, T. J. J. Am. Chem. Soc. 1965, 87, 3630. 
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!
EtO2CN
NX
R1
R2
R1 R2 X
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H
H
H
Ph
Ph
CO2Me
CO2CH2Ph
CO2CH2Ph
CO2CH2Ph
CO2CH2Ph
yield (%)
84
89
68
64
57
NX
R1 R2
:N-CO2Et
yield (%)
42
33
30
26
28
1.63 1.64 1.65
Figure 1.5: Substrate scope for synthesis of diazepines 1.65
 
Substrates containing lactam and secondary amide functionality are also 
compatible with this aziridination-fragmentation protocol.  Aziridines 1.67 were 
generated from cyclobutenes 1.66 using ethoxycarbonylnitrene followed by desilyation.  
Fragmentation of aziridines 1.67 proceeds at 140 oC to provide diazepines 1.68 in 70-
90% yield (eq. 1.14).5 
NH
EtO2CN
OR
2
R1
R1 = H, R2 = H
R1 = Me, R2 = H
R1 = H, R2 = Me
140 oC
70-90% NH
N
O
R2
R1
EtO2C
NTBS
OR2
R1
(i) :N-CO2Et
(ii) Al2O3
40-60%
1.66 1.67 1.68
(eq. 1.14)
 
Photochemical investigations using aziridines 1.69 revealed that they had 
identical reactivity to the epoxides analogs 1.14 (eq. 1.6).  Irradiation of aziridines 1.69 in 
acetonitrile generates diazepines 1.70 in 65-85% yields (eq. 1.15).8 
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N
EtO2CN
R1
R2
Ph
h!
MeCN
65-85%
EtO2CN
N
Ph
R1
R2
R1 = R2 = H
R1 = Me, R2 = H
R1 = R2 = Me
1.69 1.70
(eq. 1.15)
 
The authors suggest a mechanism for this expansion identical to the epoxide analogs (see 
Scheme 1.1) and observe similar thermal rearrangements of the ring expanded products, 
with the only difference being the diazepine rearrangements require higher temperature. 
 Applications toward the synthesis of eight membered rings 
 While the chemistry of 5-azabicyclo[2.1.0]pentanes aimed at making seven 
membered heterocycles behaved similar to the 5-oxobicyclo[2.1.0]pentanes, the 
chemistry aimed at making eight membered heterocycles showed startling differences.  
For example, irradiation of aziridines 1.71, while also not affording the expected eight 
membered ring compounds 1.72, afforded nitrile products 1.73 in 50-60% yields 
(Scheme 1.11) (for a comparison of the epoxide chemistry see Scheme 1.2).11   
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N
NEtO2CN
R
CO2Et
R = H, Me
h!
EtO2CN N
N
CO2Me
R
h!
50-60%
NH
CN
EtO2CN
R
CO2Et1.71 1.73
1.72
Scheme 1.11: Irradiation of aziridines 1.71
 
 
The authors suggest that formation of nitrile 1.73 occurs by initial cleavage of the N-N 
bond to afford diradical 1.74.  Diradical 1.74 then undergoes intramolecular hydrogen 
transfer to yield nitrile 1.73 (Scheme 1.12).11 
N
NEtO2CN
R
CO2Et
N
NEtO2CN
R
CO2Et
H
NH
CN
EtO2CN
R
CO2Et1.731.741.71
Scheme 1.12:  Proposed mechanism for formation of nitriles 1.73
 
 Thermal fragmentation of aziridines 1.71 provided alternate products and hinted 
at modes of cleavage that differ from the corresponding epoxides 1.22.  Tsuchiya 
observed that heating aziridines 1.71 in solvents at 160 oC gave complex mixtures with 
no identifiable products.  However, treating aziridines 1.71 to f.v.p. at 390 oC afforded 
“5-5” ring products 1.75 in 20-30% yields (eq. 1.16).12   
 20 
N
NEtO2CN
R
CO2Et
f.v.p.
390 oC
3 X 10-5 mmHg
20-30%
N N
N
REtO2C CO2Et
1.71 1.75
(eq. 1.16)
 
The authors propose that aziridines 1.71 may react by ionic cleavage of the aziridine C-C 
bond generating charged intermediate 1.76.  Intermediate 1.76 may react through 
resonance structure 1.77 as shown in Scheme 1.13 to produce the observed products 
1.75. 
N
N N
E
E
R
N
N N
E
E
R
N
NN
R
E
1.71
E !
1.76 1.77
N N
N
RE E
1.75
E = CO2Et
Scheme 1.13:  Proposed ionic mechanism for the formation of 1.75
 
Tsuchiya comments that this ionic fragmentation most likely proceeds in solution at 
lower temperatures, but may decompose preferentially giving rise to the complex 
mixtures observed.  In comparison the epoxide analogs 1.22 only react at higher 
temperature (f.v.p. conditions) and not at lower temperature (solution conditions).  The 
higher temperature may be required for epoxides 1.22 to undergo homolytic fission of the 
oxirane C-C bond, a necessity that is avoided in the proposed ionic fragmentation of 
aziridines 1.71.   
 Tsuchiya reports ionic fragmentation pathways with other aziridines, such as the 
benzofuran based substrates 1.78.  Heating these substrates at 160 oC in toluene or xylene 
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does not generate the expected 1,4-benzoxazocines 1.79, but rather affords rearranged 
products 1.80-1.82 (Scheme 1.14).17 
O
NCO2Et
R1
R2
160 oC
Toluene or
xylene
O
NCO2Et
R2
R1
O
R1
NCO2Et
R2
+
O
CO2Et
N
R1
R2
O
N
O
R1 R
2
+
1.78
1.79
1.80 1.81 1.82
Scheme 1.14:  Thermal fragmentation of aziridine 1.78
 
As stated before the lower reaction temperatures and isolation of rearranged products 
1.80-1.82 lend support to the involvement of ionic intermediates.  Pathways to both 1.80 
and 1.81 are thought to originate with ionic cleavage of the aziridine C-C bond affording 
zwitterion 1.83, which exists in resonance with 1.84 (Scheme 1.15).  Product 1.80 arises 
from resonance form 1.83 by migration of the phenoxy group.  Alternatively, product 
1.81 arises from resonance form 1.84 by a Wagner-Meerwein rearrangement of the 
phenyl group followed by shift of the phenoxy group.17 
                                                
(17) Kurita, J. Sakai, H.; Yamada, S.; Tsuchiya, T. J. Chem. Soc., Chem. Commun. 1987, 26, 285. 
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O
R1
NCO2Et
R2
O
CO2Et
N
R1
R2
O
R1
R2
NCHO2Et
O
R1
R2
NCHO2Et
1.83 1.84
1.80 1.81
Scheme 1.15:  Proposed ionic rearrangements to afford 1.80 and 1.81
 
 Thermolysis of indole based 1.85 did not provide the desired ring expanded 
product 1.86, but rather only generated rearranged product 1.87 (Scheme 1.16).  The 
authors suggest that the formation of 1.87 follows the same mechanism proposed for the 
formation of 1.80 in Scheme 1.15.14 
N
NCO2Et
180 oC
dichlorobenzene
90%
N
NCO2Et
COPh
PhOC
N
COPh
NCO2Et
1.85 1.87
1.86
Scheme 1.16: Thermal fragmentation of aziridine 1.85
 
 
Finally, thermal fragmentation of indene based substrates 1.88 did provide the desired 
ring expanded products 1.90 with no other rearranged products (eq. 1.17).  As with 
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previous examples, this fragmentation is proposed to occur via ionic intermediate 1.89. 
As observed in other cases (eq. 1.16), fragmentations of 1.88 performed in solution at 
180 oC afforded complex mixtures with no characterizable products.15 
NCO2Et
R2
R1
R1 = H, R2 = H
R1 = Me, R2 = H
R1 = H, R2 = Me
f.v.p.
530 oC NCO2Et
R2
R1
R2
R1
NCO2Et
1.88 1.89 1.90
(eq. 1.17)
60-80%
 
1.4 Synthesis and chemistry of 5-thiabicyclo[2.1.0]pentanes 
Corey reported the first example of a 5-thiabicyclo[2.1.0]pentane while exploring 
the photocyclization of diphenyldivinyl sulfide 1.91.  Irradiation of 1.91 in ether 
induced a [2 + 2] cycloaddition to generate episulfide 1.92 in 30-34% yield (eq. 
1.18).18  
S
Ph
H
Ph
H
h!
Et2O
30-34%
S
HH
PhPh
1.91 1.92
(eq. 1.18)
 
 Tsuchiya was able to generate episulfides19 directly from his cyclobutenes 
substrates using a method developed by Ley.20  Treatment of cyclobutene 1.6 with 
succinimide-N-sulfenyl chloride afforded the 5-chloro-6-(N-succinimidothio)-adduct 
                                                
(18) Block, E.; Corey, E. J. J. Org. Chem. 1969, 34, 896-899. 
(19) For a review of direct episulfidation of olefins see:  Adam, W.; Bargon, R. Chem. Rev. 2004, 104, 251-
261. 
(20) Bombala, M. U.; Ley, S. V. J. Chem. Soc., Perkin Trans. 1 1979,  3013-3016. 
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which was reduced using lithium aluminum hydride to provide episulfide 1.93 in 57% 
overall yield (Scheme 1.17).  Heating episulfide 1.93 in refluxing toluene induced 
fragmentation to afford thiazepine 1.93 in 72% yield.3,7 
N
CO2Me
N
CO2Me
S S
N
CO2Me
!
72%
N
O
O
S
Cl1)
2) LAH, -75 oC
57% (2 steps)
1.93 1.941.6
Scheme 1.17:  Synthesis of thiazepine 1.94
 
Using the same method of episulfidation, Tsuchiya was able to synthesize 
substrate 1.95 with the goal of generating eight membered sulfur containing 
heterocycles.  Heating 1.95 in xylenes at 160 oC resulted in desulfurization, affording 
cyclobutenes 1.96 in 60-70% yield (eq. 1.19).15 
SH
H
H
H
160 oC
xylene
60-70%
1.95 1.96
(eq. 1.19)
 
Subjecting episulfide 1.95 to f.v.p. conditions at 625 oC afforded 5H-
benzocycloheptene 1.97 and two rearranged products, 1.98 and 1.99 (eq. 1.20).  The 
authors believe that 5H-benzocycloheptene 1.97 is a result of desulfurization to 
generate 1.96, followed by opening of the cyclobutene.  An explanation is not given 
for the formation of products 1.98 and 1.99, but it is possible that they arise from 
mechanisms similar to those shown in Schemes 1.9 and 1.10. 
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SH
H
S
Sf.v.p.
625 oC
14% 26% 11%
1.95 1.97 1.98 1.99
+ + (eq. 1.20)
 
1.5 Conclusions 
This review has showcased the potential of heterobicyclo[2.1.0]pentanes in the 
synthesis of medium sized heterocycles.  While fragmentation of the “3-4-4” ring 
systems provided an efficient route to seven membered rings, fragmentation of “3-4-
5” ring systems often seemed unpredictable, leading to the isolation of several 
products.  Determining the identity of these products offered some insight into their 
mechanism of fragmentation.  Future studies will utilize these observations for the 
design of more robust fragmentation approaches. 
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Chapter 2:  Synthesis of functionalized oxepines via fragmentation of 
highly strained epoxides 
 
2.1 Introduction/Background 
 Our laboratories have long been interested in utilizing cyclobutadiene as a 
reactive intermediate in the synthesis of medium sized ring systems.  Recently our 
laboratories reported two methods for generating bicyclo[5.3.0] ring systems (5-7 ring 
systems).21  As illustrated in Scheme 2.1, both strategies begin with a cyclobutadiene 
cycloaddition22 followed by a stereoselective cyclopropanation of cyclobutene 2.123 to 
afford cyclopropane 2.2.  Thermal (eq. 2.1) or Lewis acid mediated (eq. 2.2) 
fragmentation of 2.2 affords either 5-7 skeleton 2.3 or 2.4 with the complimentary 
stereochemical outcome indicated.  Specifically, thermal fragmentation results in a 
stereochemical inversion at C10, while Lewis acid mediated fragmentation results in 
retention of this stereocenter. 
                                                
(21) Thermal:  (a) Deak, H. L.; Stokes, S. S.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 5152-5153.  
Lewis acid:  (b) Deak, H. L.; Williams, M. J.; Snapper, M. L. Org. Lett. 2005, 7, 5785-5788. 
(22) For more detail on the synthesis of iron stabilized cyclobutadiene complexes see chapter 3. 
(23) (a) Tallarico, J. A.; Randall, M. L.; Snapper, M. L. J. Am. Chem. Soc. 1996, 118, 9196-9197.  (b) 
Limanto, J.; Snapper, M. L. J. Org. Chem. 1998, 63, 6440-6441.  (c) Limanto, J.; Tallarico, J. A.; Porter, J. 
R.; Khuong, S. K.; Houk, K. N.; Snapper, M. L. J. Am. Chem. Soc. 2002, 124, 14748-14758.  (d) Limanto, 
J.; Khuong, S. K.; Houk, K. N.; Snapper, M. L. J. Am. Chem. Soc. 2003, 125, 16310-16321.  (e) Seigal, B. 
A.; An, M. H.; Snapper, M. L. Angew. Chem. Int. Ed. 2005, 44, 4929-4932. 
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Scheme 2.1:  Thermal and Lewis acid mediated fragmentations
generating bicyclo [5.3.0] ring systems
(OC)3Fe
R'
R
[O]
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A proposed mechanism that includes rationale for the stereochemical inversion at 
C10 during the thermal isomerization appears in Scheme 2.2.  This proposed mechanism 
includes two possible routes, concerted24 and radical, that both converge upon divinyl 
cyclopropane 2.6.  Starting from 2.5, one possible concerted route may involve a 
thermally allowed [σ2s+σ2a]cycloreversion via breakage of the C2-C6 and C1-C10 bonds, 
leading directly to divinyl cyclopropane 2.6.  An alternate concerted process could 
involve a thermally allowed [σ2s+σ2a]cycloreversion via breakage of the C2-C6 and C3-
C5 bonds, generating strained cycloheptadiene 2.7.  Cycloheptadiene 2.7 can undergo 
facile cope rearrangement to afford divinyl cyclopropane 2.6.   
                                                
(24) For a discussion of symmetry concerning [2+2]cycloreversions see:  Woodward, R. B.; Hoffmann, R. 
Angew. Chem., Int. Ed. 1969, 8, 781-853. 
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Scheme 2.2: Proposed mechanism for thermal isomerization
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A radical pathway can also provide divinyl cyclopropane 2.6 via initial homolytic 
cleavage of the C2-C6 bond of 2.5 affording boat diradical 2.8.  Diradical 2.8 can 
undergo a conformational change to relax to chair diradical 2.9.  Subsequent cleavage of 
the C1-C10 bond affords divinyl cyclopropane 2.6.  Divinyl cyclopropanes are known to 
undergo Cope rearrangement, but only from the bis-endo-boat conformation.25  In order 
to adopt this conformation (2.6→2.10), divinyl cyclopropane 2.6 must undergo a bond 
rotation around the C5-C6 bond.  Once conformation 2.10 is achieved, the divinyl 
cyclopropane can undergo Cope rearrangement to afford the observed 5-7 ring system 
                                                
(25) (a) Davies, H. M. L. Tetrahedron 1993, 49, 5203-5223.  (b) Hudlicky, T.; Fan, R.; Reed, J. W.; 
Gadamasetti, K. G. Org. React. 1992, 41, 1-133.  (c) Wong, H. N. C.; Hon, M. Y.; Tse, C. W.; Yip, Y. C.; 
Tanko, J.; Hudlicky, T. Chem. Rev. 1989, 89, 165-198.  (d) Schnieder, M. P.; Rau, A. J. Am. Chem. Soc. 
1979, 101, 4426-4427.  (e) Vogel, E. Angew. Chem., Int. Ed. 1963, 2, 1-11. 
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2.11.  Ultimately, it is the bond rotation around the C5-C6 bond required to adopt the bis-
endo-boat conformation that is responsible for the inversion of the stereocenter at C10. 
 The cyclopropanation/thermal fragmentation strategy proved very tolerant of a 
number of functional groups including esters (2.15→2.16), silyl ethers (2.15→2.16), 
alkyl ethers (2.17→2.18), and aryl groups (2.21→2.22) (Scheme 2.3).  All fragmentation 
reactions proceeded in good yield with stereochemical inversion at C10.    
X
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R1
X
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H H
H
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O
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O
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O
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O
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H
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O
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H H
H H
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Scheme 2.3: Cyclopropanation/fragmentation methodology for building bicyclo[5.3.0]decanes
(eq. 2.3)
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2.2 Epoxidation-fragmentation methodology for synthesizing 
functionalized oxepines 
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Building upon the cyclopropanation/fragmentation methodology, we sought to 
extend the thermal fragmentation to heterocyclic variants of the 5-7 ring system.  
Specifically we were interested in developing an epoxidation/fragmentation strategy for 
synthesizing functionalized oxepines.  
Following known cyclobutene epoxidation procedures,26 treatment of cyclobutene 
2.23 with m-CPBA in CH2Cl2 afforded the desired epoxide 2.24 in 93% yield (eq. 2.4).  
Epoxide 2.24 was isolated as a white solid, and X-ray analysis indicated that epoxidation 
occurred selectively from the less hindered face of the olefin providing the anti-
tricyclo[3.2.0.0] ring system.  This matched the selectivity observed in the 
cyclopropanation reactions.  The purity of the m-CPBA was shown to impact the reaction 
as trace amounts of m-chlorobenzoic acid lowered the yields.  As a result, the m-CPBA 
used in these epoxidations was pretreated with phosphate buffer (pH 8) to remove 
residual acid.27 
O
H
OMe
O
m-CPBA
CH2Cl2, 93%
O
H
OMe
O
O
O
O
H
H
OMe
O
H H
2.23 2.24 2.24
(eq. 2.4)
 
With epoxide 2.24 in hand, we turned our attention to the fragmentation portion 
of the synthetic strategy.  Heating epoxide 2.24 to 200 oC in benzene afforded two 
oxepine containing products, 2.25 and 2.26, in 81% overall yield (eq. 2.5).  We were able 
                                                
(26) (a) Paquette, L. A.; Youssef, A. A.; Wise, M. L. J. Am. Chem. Soc. 1967, 89, 5246-5250 and 
references cited therein.  (b) Garin, D. L. J. Org. Chem. 1969, 34, 2355-2358. 
(27)  (a) Schwartz, N. N.; Blumbergs, J. H. J. Org. Chem. 1964, 29, 1976-1979.  (b) Bortolini, O.; 
Campestrini, S.; Di Furia, F.; Modena, G. J. Org. Chem. 1987, 52, 5093-5095. (c) Traylor, T. G.; Miksztal, 
A. R. J. Am. Chem. Soc. 1987, 109, 2770-2774. 
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to separate these acid sensitive products using medium-pressure liquid chromatography 
(MPLC) with base-washed columns.28  Products 2.25 and 2.26 were isolated in similar 
amounts and resubjected individually to the reaction conditions.  Upon resubjection, no 
change was observed for either product, indicating that they are not equilibrating under 
the reaction conditions.29   
O
O
H
O
O
46% 35%
+
O
OMe
O
OMe
200 oC
PhH,
BHT
O
H
OMe
O
O
H
H
2.24 2.25 2.26
(eq. 2.5)
1 1 1
10 10 10
 
The stereochemical identities of the oxepine products 2.25 and 2.26 were 
confirmed using 1H-NMR and X-ray analysis.  1H-NMR coupling constants were used to 
determine that oxepine product 2.25 contains a syn relationship between the hydrogens at 
C1 and C10.  Since this technique could not be used for oxepine product 2.26, a solid 
derivative was synthesized in order to obtain crystals suitable for X-ray analysis.30  
Synthesis of this derivative begins with reduction of the methyl ester to afford primary 
alcohol 2.27 in 80% yield (eq. 2.6).  Coupling of primary alcohol 2.27 with 3,5-
dinitrobenzoyl chloride provides ester 2.28, which upon slow evaporation from a tert-
butyl methyl ether solution affords X-ray quality crystals.  X-ray analysis of 2.28 
indicated the hydrogens at C1 and C10 have an anti relationship.       
                                                
(28) These oxepine products decomposed slowly on untreated silica gel. 
(29) For a possible equilibration mechanism for these oxepines, see:  Crandall, J. K.; Watkins, R. J. 
Tetrahedron Lett. 1967, 8, 1717-1720. 
(30) 1H-NMR coupling constants associated with the α-proton in oxepine 2.25 provided the relative 
stereochemical identity of the syn diastereomers.  The 1H-NMR signal associated with the α-proton in 
oxepine 2.26 was overlapping with other signals and could not provide any stereochemical information. 
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2.26 2.27 2.28  
Since we were working with racemic material, it was unclear whether the syn 
diastereomer (2.25) arose from inversion at C10 to yield 2.25 or at C1 to provide 2.25′ .  
Likewise the anti diastereomer (2.26) could have arisen from either retention (2.26) or 
inversion (2.26′) at both C1 and C10 (Scheme 2.4).   
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Scheme 2.4:  Stereochemical possibilities for thermal ring openning of 2.24
 
As shown in Scheme 2.5, fragmentation pathways could be envisioned for 
providing any of these diastereomers.31 A pathway leading to a diastereomer with C1 and 
C10 retention could begin with homolytic cleavage of the C3-C5 bond in epoxide 2.29.  
This diradical (2.30) could isomerize from the anti conformation to a planar 
                                                
(31) While Scheme 2.5 depicts radical pathways, polar and concerted pathways to generate these pathways 
are also possible. 
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conformation, providing diradical 2.31.  Rearrangement of the C2-C6 bond would then 
provide oxepine product 2.32.  Oxepine product 2.33 containing inversion at C1 could be 
obtained from oxepine 2.32 by epimerization when R = CO2Me.  A pathway leading to a 
diastereomer with C1 and C10 inversion could begin with homolytic cleavage of the C2-
C6 bond in epoxide 2.29 generating boat diradical 2.34.  Rearrangement of the C1-C10 
bond would provide divinyl epoxide 2.35.  Bond rotation around both the C2-C3 and C5-
C6 bonds affords the bis-endo-boat conformation (2.36), which can undergo Cope 
rearrangement generating oxepine product 2.37.  In this case the observed inversion 
would be a result of the two bond rotations required in order to adopt the bis-endo-boat 
conformation of the divinyl epoxide.  Lastly, a diastereomer with inversion only at C10 
could arise from the same mechanism proposed for the cyclopropane analogs where one 
bond rotation is necessary in order to adopt the bis-endo-boat conformation (2.38→2.41).     
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Scheme 2.5:  Possible diradical fragmentation pathways to the oxepine diastereomers
O
 
It became a priority for us at this point to determine the absolute stereochemical 
identities of C1 and C10.  Solving this problem would provide details regarding 
fragmentation mechanisms that provide both diastereomers.  To gain information we 
chose to use a remote stereocenter that was not likely affected by the thermal 
fragmentation to determine the stereochemical outcome of the reaction.  Specifically, we 
chose to install a hydroxyl group at C7, which as illustrated in Scheme 2.5 (substituent 
labeled R′) is not affected by any of the proposed fragmentation pathways.  Epoxides 
2.42 and 2.43, both containing the hydroxyl stereocenter, underwent thermal 
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fragmentation to each afford two oxepine diastereomers in moderate yield (eqs. 2.7 & 
2.8).   Transient NOE measurements on substituted oxepines 2.44, 2.45, 2.46, and 2.47 
allowed for assignment of all the stereoisomers.  Figure 2.1 summarizes the results of 
these NOE experiments.32  The findings indicate that the diastereomers containing a syn 
relationship between the hydrogens at C1 and C10 are a result of inversion of the C10 
stereocenter.  The diastereomers containing an anti-relationship between the hydrogens at 
C1 and C10 arose from retention of both stereocenters.  These results indicate that in 
addition to formation of divinyl epoxide intermediate 2.39, which as observed in the 
cyclopropyl analogs leads to inversion of C10, the epoxide substrates also favor cleavage 
of the C3-C5 bond, which avoids formation of a divinyl epoxide intermediate and leads 
to the 5-7 ring system with retention of both C1 and C10 stereocenters. 
                                                
(32) Varian’s NOESY1D (DPFGSE NOE) experiments for measurement of transient NOEs are generally 
lower in intensity than steady-state NOE values. 
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Figure 2.1:  Results of transient 1D NOE experiments (NOESY 1D) and 
distances calculated at the AM1 level
a Value from overlapping peaks in spectra  
As shown in Table 2.1, this epoxidation-thermal fragmentation strategy was 
tolerant of functional groups including esters (entries 5, 7, 8, & 9), alkyl ethers (entries 1-
4), silyl ethers (entries 5-7), nitro groups (entry 3), and free alcohols (entries 8-9).  
Epoxidation of all cyclobutenes proceeded in > 80%, while the thermal rearrangement 
afforded two diastereomers in similar amounts.33,34 
                                                
(33) Leyhane, A. J.; Snapper, M. L. Org. Lett. 2006, 8, 5183-5186. 
(34) 1H-NMR coupling constants associated with the vinyl proton at C2 in the oxepine products can 
provide the relative stereochemical identities of the syn and anti diastereomers. 
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(99%)
(46%) (35%)
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(52%) (18%)
(48%) (23%)
(75%, 1:1)a
(32%)
epoxide (yield) thermolysis product (yield)entry
(1)
(2)
(3)
(4)
(5)
(6)
(23%)
2.24 2.25 2.26
2.48
2.49 2.50
2.51 2.52 2.53
2.54 2.55 2.56
2.57
2.58
2.59
2.60 2.61 2.62
H
H
H
H
H
H
Table 2.1:  Substrate scope for oxepine synthesis via epoxide fragmentation
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Table 2.1 (continued):
CO2Me
O
H
TBSO
CO2Me
O
H
HO
O
CO2Me
H
O
CO2Me
TBSO TBSO
O
CO2Me
H
O
CO2Me
HO HO
(89%)
(72% 1:3)a
(30%)
(7)
(8)
CO2Me
O
H
HO
O
CO2Me
H
O
CO2Me
(91%) (38%)
(9)
HO HO
(30%)
(31%)
2.43 2.46 2.47
2.42 2.44 2.45
2.63
2.64
2.65
H
H
H
a Not readily separable; product ratio determined by 1H-NMR  
Entries 1-4 in Table 2.1 explore the electronic effects on the thermal 
fragmentation.  Whereas substituents on the cyclopropyl substrates influenced the 
minimal temperature for fragmentation, neither electron-rich nor electron-poor 
substituents changed the relative rate of ring opening for the epoxide substrates.  Table 
2.2 summarizes the data displaying this trend.  In the case of the cyclopropyl analogs 
substituents that stabilize electron deficient intermediates, such as o-methoxyphenyl, 
facilitate the fragmentation.  This observation in the cyclopropyl substrates lends support 
to the involvement of the C1-C10 bond in the fragmentation process.  In the case of the 
epoxides, the absence of an electronic trend suggests a lower dependence on the 
involvement of the bonds neighboring the C1 substituent.  
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160 °C! 
160 °Ca
190 °C
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130 °C
X = CH2R X = O
a Temperature for C6H4-p-OMe
1
10
Table 2.2:  Electronic substituent effects on 
minimum fragmentation temperatures for the
cyclopropyl and epoxide substrates
 
2.3 Conclusion 
 In conclusion an epoxidation-thermal fragmentation strategy for the synthesis of 
functionalized oxepines has been presented.  Epoxidation of cyclobutenes with m-CPBA 
proceeds in excellent yield and with the same selectivity observed for cyclopropanation. 
Fragmentation of epoxides, unlike the corresponding cyclopropanes, affords a mixture of 
two diastereomers in similar amounts.  The mixture of diastereomers most likely results 
from two competing fragmentation pathways. 
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2.4 Experimental section 
General Information 
Starting materials and reagents were purchased from commercial suppliers and 
used without further purification except the following: dichloromethane, Et2O, and 
benzene were used from a solvent purification system.35  m-CPBA was washed with 
phosphate buffer (pH = 8.0) to remove acid and recrystallized from 25:1 CH2Cl2:Et2O.36 
3,5-Dinitrobenzoyl chloride was recrystallized from t-butyl methyl ether and hexanes.  
Hexanes and Et2O used in chromatography were distilled before use. 
All oxygen or moisture sensitive reactions were carried out under N2 atm. in 
oven-dried (140 °C, ≥ 4 h) or flame-dried glassware.  Air or moisture sensitive liquids 
were transferred by syringe and were introduced into the reaction flasks through rubber 
septa under positive N2 pressure.  Degassing refers to a flow of dry N2 bubbling through 
reaction solvent for 15 min.  Unless otherwise stated, reactions were stirred with a 
Teflon-covered stir bar.  Concentration refers to the removal of solvent using a Büchi 
rotary evaporator, followed by use of a vacuum pump at approximately 1 torr.  Silica gel 
chromatography refers to flash chromatography,37 and was performed using either Baxter 
brand silica gel 60 Å (230-400 Mesh ASTM) or EMD brand silica gel 60 Å (particle size 
40-63 µM).  Oxepine diastereomers were separated using a Horizon Biotage Flash 
System (MPLC) with 12-S, 12-M, or 40-M columns.    
                                                
(33) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J.  Organometallics 
1996, 15, 1518-1520. 
(34) (a) Schwartz, N. N.; Blumbergs, J. H. J. Org. Chem. 1964, 29, 1976-1979.  (b) Bortolini, O.; 
Campestrini, S.; Di Furia, F.; Modena, G. J. Org. Chem. 1987, 52, 5093-5095.  (c) Traylor, T. G.; Mikstzal, 
A. R. J. Am. Chem. Soc. 1987, 109, 2770-2774. 
(35) Stille, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925. 
 41 
Proton nuclear magnetic resonance spectra (1H-NMR) were measured on either a 
Varian Unity-300 instrument (300 MHz), a Varian Gemini-400 Instrument (400 MHz), or 
a Varian Gemini-500 instrument (500 MHz).  Chemical shifts are reported in ppm 
downfield from tetramethylsilane with the solvent reference as the internal standard 
(CHCl3: δ 7.26 ppm).  Data is reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, qi = quintet, sex = sextet, br = broad, m = 
multiplet), coupling constants (Hz), and integration.  13C-NMR spectra were recorded on 
either a Varian Unity-300 instrument (75 MHz), a Varian Gemini-400 Instrument (100 
MHz), or a Varian Gemini-500 instrument (125 MHz) with complete proton decoupling.  
Chemical shifts are reported in ppm downfield from tetramethylsilane with the solvent 
reference as the internal standard (CDCl3: δ 77.23 ppm).  Infrared spectra (IR) were 
measured on either a Mattson Galaxy Series FTIR 5000 spectrometer or a Nicolet Avatar 
360 FT-IR spectrometer and are reported in wave numbers (cm-1).  Bands are 
characterized as broad (br), strong (s), medium (m), or weak (w).  Elemental analyses 
(Anal.) were performed by Robertson Microlit Laboratories, Inc., Madison, NJ and are 
reported in percent atomic abundance.  High resolution mass spectral analyses (HRMS) 
were performed by the Mass Spectrometry Laboratory, University of Illinois at Urbana-
Champaign. 
X-ray data were collected using a Bruker APEX CCD (charged coupled device) 
based diffractometer equipped with an LT-2 low temperature apparatus operating at 193 
K. A suitable crystal was chosen and mounted on a glass fiber using grease.  Data were 
measured using omega scans of 0.3° per frame for 45 seconds, such that a hemisphere 
 42 
was collected.  A total of 1305 frames were collected with a maximum resolution of 0.90 
Å.  Cell parameters were retrieved using SMART software38 and refined using SAINT on 
all observed reflections.  Data reduction was performed using the SAINT software,39 
which corrects for Lp and decay.  Absorption corrections were applied using SADABS, 
supplied by George Sheldrick.  The structures were solved by the direct method using the 
SHELXS-97 program40 and refined by least squares method on F2, SHELXL-97,41 
incorporated in SHELXTL-PC V 6.10.42 
All non-hydrogen atoms are refined anisotropically.  Hydrogens were calculated 
by geometrical methods and refined as a riding model. The crystal used for the diffraction 
study showed no decomposition during data collection.  All drawings are done at 30% 
ellipsoids. 
NOESY 1D experiments were measured on a Varian Gemini-500 instrument (500 
MHz) with an indirect probe.  Sample size was 5 mg and all samples were degassed to 
remove oxygen.  The number of transients was 512 and the relaxation time was 800 ms. 
NOESY1D is the Varian implementation of the 1D NOE experiment using pulsed field 
gradients and selective pulses developed by Shaka et al. The experiment involves a 
double-pulsed-field-gradient-spin-echo (DPFGSE) pulse sequence that achieves selective 
                                                
(38) SMART V5.626 (NT) Software for the CCD Detector Systems; Bruker Analytical X-ray Systems, 
Madison, WI (2001). 
(39) SAINT V 5.01 (NT) Software for the CCD Detector Systems; Bruker Analytical X-ray Systems, 
Madison, WI (2001). 
(40) Sheldrick, G. M. SHELXS-90, Program for the Solution of Crystal Structure, University of Göttingen, 
Germany, 1990. 
(41) Sheldrick, G. M. SHELXL-97, Program for the Refinement of Crystal Structure, University of 
Göttingen, Germany, 1997. 
(42) SHELXTL 6.0 (PC-Version), Program Library for Structure Solution and Molecular Graphics; Bruker 
Analytical X-ray Systems, Madison, WI (1998). 
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spin inversion effectively and cleanly.  The NOE values obtained from the experiment 
were interpreted qualitatively and compared to the relative proton distances to assign the 
stereochemistry.  
Experimental Procedures 
O
OMe
O
m-CPBA, 
CH2Cl2
93%
O
OMe
O
O
H H
2.23 2.24  
A round bottom flask (25 mL) was charged with cyclobutene 2.2343 (348 mg, 1.90 
mmol) in CH2Cl2 (5.1 mL) and m-CPBA (557 mg, 3.23 mmol).  The flask was flushed 
with N2, and the reaction was stirred at room temperature (rt).   The consumption of 
starting material was monitored by TLC.  Upon completion (3 h), the reaction was 
quenched with Na2S2O3(sat. aq.) (5 mL) and allowed to stir for 1 h.  The mixture was 
diluted with CH2Cl2 (20 mL), and the organic layer was separated, washed with 
NaHCO3(sat. aq.), dried over MgSO4, filtered and concentrated in vacuo.  The resulting 
white solid was purified by silica gel chromatography (1:1 hexanes:Et2O).  Epoxide 2.24 
was obtained in 93% yield (346 mg, 1.76 mmol) and was recrystallized from t-butyl 
methyl ether to afford crystals suitable for X-ray analysis. 
Epoxide 2.24:  mp = 78-79 °C.  1H-NMR (400 MHz, CDCl3): δ 4.06 (m, 2H), 
3.97 (d, J = 9.6 Hz, 1H), 3.86 (d, J = 10.4 Hz, 1H), 3.73 (m, 1H) 3.73 (s, 3H), 3.45 (d, J = 
10.4 Hz, 1H), 3.21, (dd, J = 8.0, 5.2 Hz, 1H), 3.06, (t, J = 5.2 Hz, 1H), 2.79, (dd, J = 8.0, 
                                                
(43) (a) Deak, H. L.; Stokes, S. S.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 5152-5153.  (b) Bader, S. 
J.; Snapper, M. L. J. Am. Chem. Soc. 2005, 127, 1201-1205. 
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3.6 Hz, 1H).    13C-NMR (100 MHz, CDCl3): δ 172.8, 73.4, 69.7, 60.4, 54.4, 52.3, 51.8, 
46.6, 42.1, 41.4.  IR (KBr pellet) 3428 (br), 2987 (m), 2965 (m), 2920 (m), 2861 (m), 
1725 (s), 1440 (m), 1341 (m), 1312 (m), 1264 (s), 1093 (s), 822 (m) cm-1.  Anal. Calcd 
for C10H12O4: C, 61.22; H, 6.16.  Found:  C, 61.40; H, 6.08. 
O
OMe
O
O
H
2.24
200 °C, 
2 h
BHT, PhH 
[0.01 M] O
O
OMe
O
H
+
(46%) (35%)
O
O
OMe
O
H
2.25 2.26  
A degassed solution of 2.24 (68.0 mg, 0.347 mmol) and BHT (115 mg, 0.521 
mmol) in benzene (34.7 mL) in a heavy-wall sealed tube (150 mL) was placed in a 
silicone oil bath and heated to 200 °C.  The reaction was monitored by TLC and stopped 
upon consumption of starting material (2 h).  Concentration in vacuo, followed by 
filtration through basic alumina (1 cm plug) with hexanes (to separate BHT) followed by 
Et2O afforded two diastereomers as a colorless oil.  Medium pressure liquid 
chromatography (10-30% hexanes:Et2O) with a base-washed column (1% pyridine in 
EtOAc) was used to separate the diastereomers.  Oxepine 2.25 was obtained as a 
colorless oil in 46% yield (31 mg, 0.16 mmol), and oxepine 2.26 was obtained as a 
colorless oil in 35% yield (24 mg, 0.12 mmol).  
Oxepine 2.25:  1H-NMR (400 MHz, CDCl3): δ 6.43 (s, 1H), 6.33 (d, J = 8.0 Hz, 
1H), 4.77 (t, J = 8.0 Hz, 1H), 4.48 (d, J = 11.6 Hz, 1H), 4.34 (d, J = 11.6 Hz, 1H), 4.04 (t, 
J = 8.4 Hz, 1H), 3.74 (dd, J = 8.8, 6.8 Hz, 1H), 3.70 (s, 3H), 3.47 (dd, J = 8.0, 3.6 Hz, 
1H), 3.34 (m, 1H).  13C-NMR (100 MHz, CDCl3): δ 171.9, 144.5, 134.1, 121.3, 102.2, 
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72.6, 70.7, 52.5, 45.9, 44.6.  IR (NaCl thin film):  3055 (w), 2924 (w), 2853 (w), 
2361(w), 2341(w), 1740 (m), 1651 (w), 1266 (s), 1196 (w), 1152 (m), 738 (s), 704 (w) 
cm-1.  EI HRMS: Calcd for C10H12O4 (+M): 196.0736; Found: 196.0732. 
Oxepine 2.26:  1H-NMR (400 MHz, CDCl3): δ 6.38 (s, 1H), 6.23 (d, J = 8.0 Hz, 
1H), 4.82 (d, J = 8.0, 1H), 4.33 (m, 2H), 4.15 (m, 1H), 3.74 (s, 3H), 3.61 (m, 1H), 3.34 
(m, 2H).  13C-NMR (100 MHz, CDCl3): δ 172.6, 142.5, 134.9, 120.5, 104.5, 73.8, 70.3, 
52.5, 46.6, 45.0.  IR (NaCl thin film):  2954 (m), 2849 (m), 1737 (s), 1695 (m), 1656 (m), 
1435 (w), 1361 (w), 1302 (w), 1156 (m) cm-1.  Anal. Calcd for C10H12O4: C, 61.22; H, 
6.16.  Found:  C, 61.35; H, 6.40. 
O
O
OMe
O
H
2.26
LAH, Et2O, 0 °C
80% O
O
OH
H
2.27  
 A round bottom flask (5 mL) was charged with oxepine 2.26 (30.8 mg, 
0.157 mmol) in Et2O (2.0 mL). The solution was then flushed with N2 and cooled to 0 °C 
in an ice bath.   An LAH solution (0.47 mL, 0.47 mmol, 1 M in Et2O) was added 
dropwise by syringe to the reaction.  The consumption of starting material was monitored 
by TLC.  Upon completion (1 h), the reaction was treated with of H2O (50 µL), 15% 
aqueous NaOH (50 µL), and then H2O (150 µL).  After this treatment, a white precipitate 
formed and settled to the bottom of the flask.  The reaction mixture was filtered, and the 
salts were washed with Et2O (3 x 5mL).  The filtrate was concentrated in vacuo to afford 
a colorless oil.  The resulting oil was purified by medium pressure liquid chromatography 
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(1.5:1 hexanes:EtOAc) using a base-washed column (1% pyridine in EtOAc).  Oxepine 
2.27 was obtained in 80% yield (21 mg, 0.12 mmol) as a colorless oil.  
Oxepine 2.27:  1H-NMR (400 MHz, CDCl3): δ 6.36 (d, J = 2.4 Hz, 1H), 6.25 (dd, 
J = 7.6, 2.4 Hz, 1H), 4.64 (dd, J = 8.0, 2.8 Hz, 1H), 4.38 (d, J = 11.6 Hz, 1H), 4.28 (dt, J 
= 12.0, 2.0 Hz, 1H), 4.20 (t, J = 8.0 Hz, 1H), 3.59 (m, 4H), 3.09 (q, J = 8.0 Hz, 1H), 2.54 
(m, 1H).  13C-NMR (100 MHz, CDCl3): δ 142.7, 134.5, 121.2, 107.5, 73.5, 70.1, 65.9, 
44.8, 43.1.  IR (NaCl thin film): 3421 (br), 2921 (s), 2856 (s), 1694 (s), 1654 (s), 1359 
(m), 1308 (m), 1206 (m), 1160 (s), 1108 (m), 1071 (m), 1039 (s), 967 (m), 927 (m), 867 
(m), 747 (m), 709 (m) cm-1.  EI HRMS: Calcd for C9H12O3 (+M): 168.0787; Found: 
168.0786.    
O
O
OH
H
O
O
O
H
O NO2
NO2
3, 5-dinitrobenzoyl chloride
CH2Cl2, DMAP
84%
2.27 2.28  
A round bottom flask (10 mL) was charged with oxepine 2.27 (10.0 mg, 0.0595 
mmol) in CH2Cl2 (2.0 mL).  3,5-Dinitrobenzoyl chloride (20.6 mg, 0.0892 mmol) was 
added to the reaction vessel as a solid.  The reaction mixture was then flushed with N2 
and cooled to 0 °C in an ice bath.  4-Dimethylaminopyridine (10.9 mg, 0.0892 mmol) 
dissolved CH2Cl2 (1.0 mL) was added to the reaction by syringe.  The consumption of 
starting material was monitored by TLC.  Upon completion (1.5 h), the reaction was 
quenched with NH4Cl(sat. aq.) (2.0 mL).  The organic layer was separated and the 
aqueous layer was extracted with CH2Cl2 (4 x 4.0 mL).  The organic layers were 
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combined, dried over MgSO4, filtered and concentrated in vacuo.  The resulting solid was 
purified by medium pressure liquid chromatography (3:1 hexanes:EtOAc) using a base-
washed column (1% pyridine in EtOAc).  Oxepine 2.28 was obtained in 84% yield (18.1 
mg, 50.0 µmol) as a thick yellow gum and was crystallized by slow evaporation of t-butyl 
methyl ether to afford yellow crystals suitable for X-ray analysis. 
Oxepine 2.28: mp = 121-122 °C.  1H-NMR (400 MHz, CDCl3): δ 9.25 (t, J = 2.8 
Hz, 1H), 9.14 (d, J = 2.8 Hz, 2H), 6.40 (d, J = 2.8 Hz, 1H), 6.27 (dd, J = 10.8, 3.6 Hz, 
1H), 4.69 (dd, J = 10.8, 3.6 Hz, 1H), 4.38 (m, 4H), 4.23 (t, J = 10.8 Hz, 1H), 3.66 (t, J = 
11.6 Hz, 1H), 3.12 (m, 1H), 2.91 (m, 1H).  13C-NMR (100 MHz, CDCl3): δ 162.5, 148.8, 
142.9, 134.9, 133.5, 129.5, 122.7, 120.5, 106.1, 73.2, 70.2, 69.1, 45.1, 40.1.   IR (NaCl 
thin film): 3099 (m), 2919 (m), 2850 (m), 2360 (w), 2342 (w), 1732 (s), 1695 (m), 1655 
(m), 1629 (m), 1597 (w), 1544 (s), 1462 (m), 1345 (s), 1278 (s), 1207 (w), 1162 (s), 1120 
(m), 1075 (m), 1027 (m), 974 (w), 923 (m), 867 (w), 831 (w), 773 (w), 730 (s), 721 (s) 
cm-1.  EI HRMS: Calcd for C16H14N2O8 (+M): 362.0750; Found: 362.0746. 
m-CPBA, 
CH2Cl2
89%
O
H H
2.42
O
OMe OMe
O
HO HO
I  
A round bottom flask (50 mL) was charged with cyclobutene I44 (610 mg, 3.14 
mmol) in CH2Cl2 (7.8 mL) and m-CPBA (596 mg, 3.45 mmol).  The flask was flushed 
with N2 and allowed to stir at rt.  The consumption of starting material was monitored by 
                                                
(44) Williams, M. J.; Deak, H. L.; Snapper, M. L. J. Am. Chem. Soc. 2007, 129, 486-487.  
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TLC.  Upon completion (1.5 h), the reaction was quenched with Na2S2O3(sat. aq.) (5.0 
mL), diluted with CH2Cl2 (5.0 mL) and allowed to stir for 1 h.  The mixture was diluted 
with CH2Cl2 (60 mL) and the organic layer was separated, washed with NaHCO3(sat. aq.), 
dried over MgSO4, filtered and concentrated in vacuo.  The resulting oil was purified by 
silica gel chromatography (1:2 hexanes:Et2O).  Epoxide 2.42 was obtained in 89% yield 
as a white solid (577 mg, 2.74 mmol).  
Epoxide 2.42:  mp = 84-86 °C.  1H-NMR (400 MHz, CDCl3): δ 4.16 (dd, J = 9.6, 
6.4 Hz, 1H), 4.09 (d, J = 2.0 Hz, 1H), 4.01 (t, J = 3.2 Hz, 1H), 3.73 (s, 3H), 3.02 (m, 2H), 
2.80 (dd, J = 8.0, 4.4 Hz, 1H), 2.10 (m, 1H), 1.85 (m, 2H), 1.69 (m, 2H). 13C-NMR (100 
MHz, CDCl3): δ 172.9, 73.3, 61.7, 55.4, 51.9, 51.8, 41.8, 41.7, 38.8, 33.6, 28.1.  IR (KBr 
pellet): 3466 (br), 2987 (m), 2960 (m), 2867 (m), 2355 (w), 2333 (w), 1723 (s), 1435 (m), 
1310 (m), 1217 (s), 1085 (s), 813 (s) cm-1.  HRMS (m/z): Calcd for (M+Na): 233.0790.  
Found: 233.0792.       
O
H
2.42
OMe
O
HO
230 °C, 
3 h
BHT, PhH, 
[0.01 M]
O
H
+
(30%)
O
H
2.44 2.45
O
OMe
O
OMe
HO HO (30%)  
A degassed solution of 2.42 (100 mg, 0.476 mmol) and BHT (157 mg, 0.714 
mmol) in benzene (47.6 mL) in a heavy-wall sealed tube (350 mL) was placed in a 
silicone oil bath and heated to 230 °C.  The reaction was monitored by TLC and stopped 
upon consumption of starting material (3 h).  Concentration in vacuo, followed by 
filtration through basic alumina (1 cm plug) with hexanes (to separate BHT) followed by 
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Et2O afforded two diastereomers as a colorless oil.  Medium pressure liquid 
chromatography (1% MeOH:CH2Cl2) with a base-washed column (1% pyridine in 
EtOAc) was used to separate the diastereomers.  Oxepine 2.44 was obtained as a light 
yellow oil in 30% yield (30 mg, 0.14 mmol), and oxepine 2.45 was obtained as a light 
yellow oil in 30% yield (30 mg, 0.14 mmol).  
Oxepine 2.44:  1H-NMR (400 MHz, CDCl3): δ 6.58 (s, 1H), 6.30 (d, J = 8.0 Hz, 
1H), 4.80 (t, J = 8.0 Hz, 1H), 4.76 (m, 1H), 3.73 (s, 1H), 3.66 (s, 3H), 3.45 (dd, J = 8.4, 
4.0 Hz, 1H), 3.23 (m, 1H), 2.10 (m, 1H), 1.94 (m, 1H), 1.58 (m, 2H).  13C-NMR (100 
MHz, CDCl3): δ 172.3, 144.0, 138.1, 126.8, 103.2, 75.9, 52.1, 48.2, 42.5, 35.5, 28.5.  IR 
(NaCl thin film): 3417 (br), 2925 (s), 2853 (m), 1733 (s), 1683 (s), 1652 (s), 1436 (m), 
1313 (m), 1197 (s), 1093 (m), 1037 (w), 993 (w), 961 (w), 855 (w), 736 (m), 701 (w)  
cm-1.  EI HRMS:  Calcd for C11H14O4 (+M):  210.0892; Found: 210.0890. 
Oxepine 2.45:  1H-NMR (400 MHz, CDCl3): δ 6.58 (d, J = 2.4 Hz, 1H), 6.22 (dd, 
J = 8.0, 2.8 Hz, 1H), 4.71 (dd, J = 8.0, 2.4 Hz, 1H), 4.57 (m, 1H), 3.73 (s, 3H), 3.28 (dt, J 
= 8.8, 2.4 Hz, 1H), 3.07 (m, 1H), 1.85 (m, 5H).  13C-NMR (100 MHz, CDCl3): δ 173.2, 
142.3, 140.3, 127.8, 105.1, 75.1, 52.3, 49.6, 45.2, 35.5, 29.5.  IR (NaCl thin film): 3430 
(br), 2954 (m), 1736 (s), 1681 (m), 1654 (m), 1436 (m), 1352 (m), 1268 (m), 1196 (m), 
1171 (m), 1024 (m), 737 (s), 703 (m).  EI HRMS:  Calcd for C11H14O4 (+M):  210.0892; 
Found: 210.0897. 
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A round bottom flask (5 mL) was charged with cyclobutene II44 (83 mg, 0.43 
mmol) in CH2Cl2 (1.2 mL) and m-CPBA (81 mg, 0.47 mmol).  The flask was flushed with 
N2 and allowed to stir at rt.  The consumption of starting material was monitored by TLC.  
Upon completion (1.5 h) the reaction was quenched with Na2S2O3(sat. aq.) (1.0 mL), 
diluted with CH2Cl2 (1.0 mL) and allowed to stir for 1 h.  The mixture was diluted with 
CH2Cl2 (30 mL) and the organic layer was separated, washed with NaHCO3(sat. aq.), 
dried over MgSO4, filtered and concentrated in vacuo.  The resulting oil was purified by 
silica gel chromatography (1:1 hexanes:Et2O).  Epoxide 2.43 was obtained in 91% yield 
as a white solid (82 mg, 0.39 mmol). 
Epoxide 2.43:  mp = 53-56 °C.  1H-NMR (400 MHz, CDCl3): δ 4.10 (d, J = 2.0 
Hz, 1H), 4.04 (m, 2H), 3.73 (s, 3H), 2.93 (m, 2H), 2.57 (dd, J = 8.0, 4.0 Hz, 1H), 2.14 
(m, 1H), 1.91 (dd, J = 13.2, 6.8 Hz, 1H), 1.81 (m, 2H), 1.68 (dd, J = 13.2, 7.2 Hz, 1H).  
13C-NMR (100 MHz, CDCl3): δ 173.2, 71.0, 63.6, 53.4, 52.2, 52.0, 44.3, 41.2, 39.4, 34.1, 
29.5.  IR (KBr pellet): 3455 (br), 2971 (m), 2905 (m), 1718 (s), 1440 (m), 1212 (s), 819 
(m) cm-1.  HRMS (m/z): Calcd for (M + Na): 233.0790.  Found: 233.0783.  
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A degassed solution of 2.43 (24 mg, 0.11 mmol) and BHT (38 mg, 0.17 mmol) in 
benzene (11.4 mL) in a heavy-wall sealed tube (35 mL) was placed in a silicone oil bath 
and heated to 230 °C.  The reaction was monitored by TLC and stopped upon 
consumption of starting material (3 h).  Concentration in vacuo, followed by filtration 
through basic alumina (1 cm plug) with hexanes (to separate BHT) followed by Et2O 
afforded two diastereomers as a colorless oil.  Medium pressure liquid chromatography 
(10-30% hexanes:Et2O) with a base-washed column (1% pyridine in EtOAc) was used to 
separate the diastereomers.  Oxepine 2.46 was obtained as a colorless oil in 38% yield 
(9.0 mg, 0.043 mmol), and oxepine 2.47 was obtained as a colorless oil in 31% yield (7.5 
mg, 0.036 mmol).  
Oxepine 2.46:  1H-NMR (400 MHz, CDCl3): δ 6.66 (d, J = 2.8 Hz, 1H), 6.27 (d, 
J = 8.0 Hz, 1H), 4.79 (t, J = 8.0 Hz, 1H), 4.50 (m, 1H), 3.79 (d, J = 8.0 Hz, 1H), 3.72 (s, 
3H), 3.52 (dd, J = 8.0, 2.8 Hz, 1H), 3.02 (m, 1H), 1.80 (m, 4H).  13C-NMR (100 MHz, 
CDCl3): δ 173.5, 144.0, 139.4, 128.2, 102.2, 75.1, 52.5, 47.0, 43.3, 37.4, 28.8.  IR (NaCl 
thin film): 3497 (br), 2955 (s), 2878 (w), 1725 (s), 1649 (m), 1436 (w), 1309 (w), 1201 
(s) cm-1.  EI HRMS:  Calcd for C11H14O4 (+M): 210.0892; Found: 210.0897.  
 52 
Oxepine 2.47:  1H-NMR (400 MHz, CDCl3): δ 6.55 (s, 1H), 6.23 (dd, J = 8.0 Hz, 
2.4 Hz, 1H), 4.77 (dd, J = 8.0, 2.4 Hz, 1H), 4.59 (t, J = 5.6 Hz, 1H), 3.73 (s, 3H), 3.22 
(m, 1H), 3.14 (dt, J = 9.2, 2.8 Hz, 1H), 2.10 (m, 1H), 1.94 (m, 1H), 1.55 (m, 3H).  13C-
NMR (100 MHz, CDCl3): δ 173.2, 142.3, 139.8, 127.0, 106.0, 75.6, 52.3, 48.9, 44.0, 
34.6, 29.3.  IR (NaCl thin film): 3423 (br), 2954 (m), 1736 (s), 1681 (m), 1655 (m), 1437 
(m), 1350 (m), 1274 (m), 1193 (m), 1167 (m), 1134 (m), 1059 (m), 1028 (m), 739 (m) 
cm-1.  EI HRMS:  Calcd for C11H14O4 (+M):  210.0892; Found: 210.0888.       
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A round bottom flask (5 mL) was charged with cyclobutene III43 (50 mg, 0.25 
mmol) in CH2Cl2 (0.68 mL) and m-CPBA (65 mg, 0.38 mmol).  The flask was flushed 
with N2 and allowed to stir at rt.  The consumption of starting material was monitored by 
TLC.  Upon completion (1 h), the reaction was quenched with Na2S2O3(sat. aq.) (1.5 mL), 
diluted with CH2Cl2 (1.5 mL) and allowed to stir for 1 h.  The mixture was diluted with 
CH2Cl2 (20 mL) and the organic layer was separated, washed with NaHCO3(sat. aq.), 
dried over MgSO4, filtered and concentrated in vacuo.  The resulting oil was purified by 
silica gel chromatography (1:1 hexanes:Et2O).  Epoxide 2.48 was obtained in 98% yield 
as a light yellow oil (53 mg, 0.25 mmol). 
Epoxide 2.48:  1H-NMR (400 MHz, CDCl3): δ 7.35 (t, J = 8.0 Hz, 2H), 7.23 (m, 
3H), 4.03 (m, 2H), 3.95 (d, J = 10.4 Hz, 1H), 3.82 (dd, J = 10.0, 6.8 Hz, 1H), 3.75 (s, 
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1H), 3.69 (t, J = 7.6 Hz, 1H), 3.53 (d, J = 10.4 Hz, 1H), 3.09 (t, J = 6.0 Hz, 1H), 2.99 (dd, 
J = 8.4, 4.0 Hz, 1H).  13C-NMR (100 MHz, CDCl3): δ 140.6, 128.2, 126.3, 126.0, 73.4, 
69.4, 59.2, 54.2, 51.4, 48.9, 43.7, 42.3.  IR (NaCl thin film): 3056 (w), 2961 (w), 2851 
(w), 2360 (w), 1266 (w), 736 (m), 701 (m) cm-1.  Anal. Calcd for C14H14O2: C, 78.48; H, 
6.59. Found C, 78.27; H, 6.87. 
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A degassed solution of epoxide 2.48 (178 mg, 0.831 mmol) and BHT (275 mg, 
1.25 mmol) in benzene (83.1 mL) in a heavy-wall sealed tube (350 mL) was placed in a 
silicone oil bath and heated to 200 °C.  The reaction was monitored by TLC and stopped 
upon consumption of starting material (2.5 h).  Concentration in vacuo, followed by 
filtration through basic alumina (1 cm plug) with hexanes (to separate BHT) followed by 
Et2O afforded two diastereomers as a colorless oil.  Medium pressure liquid 
chromatography (5-10% Et2O:hexanes) with a base-washed column (1% pyridine in 
EtOAc) was used to separate the diastereomers.  Oxepine 2.49 was obtained as a 
colorless oil (becomes solid at colder temperatures) in 53% yield (94.8 mg, 0.393 mmol), 
and oxepine 2.50 was obtained as a colorless oil (becomes solid at colder temperatures) 
in 15% yield (27.5 mg, 0.128 mmol). 
Oxepine 2.49:  mp = 46-48 °C.  1H-NMR (400 MHz, CDCl3): δ 7.26 (m, 5H), 
6.49 (s, 1H), 6.34 (d, J = 8.0 Hz, 1H), 4.92 (t, J = 8.0 Hz, 1H), 4.19 (d, J = 11.6 Hz, 1H), 
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3.97 (t, J = 8.0 Hz, 1H), 3.90 (dt, J = 11.6, 2.0 Hz, 1H), 3.72 (dd, J = 8.0, 4.0 Hz, 1H), 
3.64 (m, 1H), 3.41 (t, J = 8.0 Hz, 1H).  13C-NMR (100 MHz, CDCl3): δ 142.4, 141.4, 
134.3, 129.8, 128.2, 127.0, 121.6, 108.9, 71.9, 70.2, 46.9, 46.0.  IR (KBr pellet):  3020 
(m), 2960 (m), 2856 (m), 2813 (m), 2361 (w), 1696 (m), 1636 (s), 1304 (s), 1152 (s) cm-1.  
Anal. Calcd for C14H14O2: C, 78.48; H, 6.59. Found C, 78.32; H, 6.47. 
Oxepine 2.50:  mp = 60-62 °C.  1H-NMR (400 MHz, CDCl3): δ 7.33 (m, 2H), 
7.24 (m, 1H), 7.18 (m, 2H), 6.45 (s, 1H), 6.23 (dd, J = 8.0, 2.8 Hz, 1H), 4.71 (dd, J = 8.0, 
2.8 Hz, 1H), 4.39 (m, 2H), 3.64 (dd, J = 9.2, 7.6 Hz, 1H), 3.49 (m, 2H), 3.28 (m, 1H).  
13C-NMR (100 MHz, CDCl3): δ 144.0, 141.0, 135.0, 128.9, 127.6, 127.0, 122.0, 111.4, 
73.8, 70.7, 49.8, 47.2.  IR (KBr pellet):  3036 (w), 2998 (m), 2905 (m), 2845 (s), 1702 
(s), 1653 (s), 1299 (s), 1162 (s).  EI HRMS: Calcd for C14H14O2 (+M): 214.0994; Found: 
214.0989. 
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A round bottom flask (5 mL) was charged with cyclobutene IV43 (52.3 mg, 0.215 
mmol) in CH2Cl2 (0.57 mL) and m-CPBA (72.5 mg, 0.430 mmol).  The flask was flushed 
with N2 and allowed to stir at rt.  The consumption of starting material was monitored by 
TLC.  Upon completion (4 h), the reaction was quenched with Na2S2O3(sat. aq.) (1.5 mL), 
diluted with CH2Cl2 (1.5 mL) and allowed to stir for 1 h.  The mixture was diluted with 
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CH2Cl2 (20 mL) and the organic layer was separated, washed with NaHCO3(sat. aq.), 
dried over MgSO4, filtered and concentrated in vacuo.  The resulting oil was purified by 
silica gel chromatography (1:1 hexane:Et2O).  Epoxide 2.51 was obtained in 97% yield as 
a light yellow solid (53 mg, 0.20 mmol).   
Epoxide 2.51:  mp = 146-148 °C.  1H-NMR (400 MHz, CDCl3): δ 8.22 (d, J = 
8.8 Hz, 2H), 7.37 (d, J = 8.8 Hz, 2H), 4.06 (m, 2H), 3.97 (d, J = 10.4 Hz, 1H), 3.85 (dd, J 
= 10.0, 6.4 Hz, 1H), 3.78 (t, J = 7.2 Hz, 1H), 3.68 (d, 1.6 Hz, 1H), 3.54 (d, 10.8 Hz, 1H), 
3.13 (t, J = 6.4 Hz, 1H), 3.04 (dd, J = 8.0, 3.6 Hz, 1H).  13C-NMR (100 MHz, CDCl3): δ 
148.9, 146.8, 127.7, 124.1, 73.3, 69.9, 60.0, 54.7, 51.6, 49.3, 44.3, 42.7.  IR (KBr pellet): 
3440 (br), 3072 (w), 2969 (w), 2923 (w), 2863 (w), 1596 (m), 1513 (s), 1346 (s), 1316 
(m) cm-1.  Anal. Calcd for C14H13NO4: C, 64.86; H, 5.05; N, 5.40.  Found: C, 65.05; H, 
5.30; N, 5.12.  
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A degassed solution of 2.51 (23.7 mg, 0.0914 mmol) and in benzene (9.1 mL, 10 
mM) in a heavy-wall sealed tube (35 mL) was placed in a silicone oil bath and heated to 
220 °C.  The reaction was monitored by TLC and stopped upon consumption of starting 
material (4.5 h).  Concentration in vacuo, followed by medium pressure liquid 
chromatography (10-20% Et2O:hexanes) with a base-washed column (1% pyridine in 
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EtOAc) was used to separate the diastereomers.  Oxepine 2.52 was obtained as a yellow 
solid in 52% yield (12.4 mg, 0.0478 mmol), and oxepine 2.53 was obtained as a yellow 
solid in 18% yield (4.3 mg, 0.018 mmol). 
Oxepine 2.52:  mp = 103-104 °C.  1H-NMR (400 MHz, CDCl3): δ 8.15 (d, J = 
8.0 Hz, 2H), 7.40 (d, J = 8.0 Hz, 2H), 6.55 (s, 1H), 6.40 (d, J = 8.0 Hz, 1H), 4.90 (t, J = 
8.0 Hz, 1H), 4.15 (d, J = 11.6 Hz, 1H), 3.95 (m, 2H), 3.87 (dd, J = 7.6, 4.0 Hz, 1H), 3.67 
(m, 1H), 3.46 (dd, J = 9.2, 6.0 Hz, 1H).  13C-NMR (100 MHz, CDCl3): δ 149.2, 143.2, 
134.8, 130.4, 128.4, 123.3, 121.2, 107.4, 71.8, 70.9, 46.7, 46.5.  IR (KBr pellet): 3440 
(br), 3075 (m), 3053 (m), 3029 (s), 2942 (s), 2903 (s), 2849 (s), 1648 (w), 1449 (s), 1351 
(m), 1153 (w), 1020 (m), 910 (m).  EI HRMS: Calcd for C14H13NO4 (+M): 259.0845; 
Found: 259.0840. 
Oxepine 2.53:  mp = 130-132 °C.  1H-NMR (400 MHz, CDCl3): δ 8.21 (d, J = 
8.0 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 6.48 (d, J = 2.0 Hz, 1H), 6.28 (dd, J = 8.0, 2.8 Hz, 
1H), 4.61 (dd, J = 8.0, 2.4 Hz, 1H), 4.40 (t, J = 1.6 Hz, 2H), 3.64 (m, 2H), 3.43 (dd, J = 
8.8, 6.8 Hz, 1H), 3.28 (m, 1H).   13C-NMR (100 MHz, CDCl3): δ 151.0, 141.9, 135.3, 
128.6, 124.3, 121.9, 109.3, 73.4, 70.6, 49.5, 46.9.  IR (KBr pellet): 3466 (br), 3061 (w), 
3027 (s), 2919 (s), 2853 (w), 1693 (w), 1649 (m), 1598 (w), 1519 (s), 1349 (s), 1300 (m), 
1154 (m), 936 (m), 753 (m).  EI HRMS: Calcd for C14H13NO4 (+M): 259.0845; Found: 
259.0849. 
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A round bottom flask (5 mL) was charged with cyclobutene V43 (106 mg, 0.464 
mmol) in CH2Cl2 (1.2 mL) and m-CPBA (148 mg, 0.858 mmol).  The flask was flushed 
with N2 and allowed to stir at rt.  The consumption of starting material was monitored by 
TLC.  Upon completion (2 h), the reaction was quenched with Na2S2O3(sat. aq.) (1.5 mL), 
diluted with CH2Cl2 (1.5 mL) and allowed to stir for 1 h.  The mixture was diluted with 
CH2Cl2 (20 mL) and the organic layer was separated, washed with NaHCO3(sat. aq.), 
dried over MgSO4, filtered and concentrated in vacuo.  The resulting oil was purified by 
silica gel chromatography (1:1 hexanes:Et2O).  Epoxide 2.54 was obtained in 97% yield 
as a white solid (109 mg, 0.446 mmol).  
Epoxide 2.54:  mp = 82-84 °C.  1H-NMR (400 MHz, CDCl3): δ 7.13 (d, J = 8.4 
Hz, 2H), 6.88 (d, J = 8.4 Hz, 2H), 4.04 (dd, J = 3.6, 2.0 Hz, 1H), 4.02 (d, J = 12.0, 1H), 
3.93 (d, J = 10.0 Hz, 1H), 3.80 (m, 1H), 3.80 (s, 3H), 3.75 (d, J = 2.0 Hz, 1H), 3.62 (t, J = 
6.8 Hz, 1H), 3.52 (d, J = 10.0 Hz, 1H), 3.04 (t, J = 6.0 Hz, 1H), 2.95, (dd, J = 8.0, 3.6 Hz, 
1H).  13C-NMR (100 MHz, CDCl3): δ 157.8, 132.9, 127.5, 113.8, 73.6, 69.6, 59.2, 55.3, 
54.5, 51.6, 49.2, 44.1, 41.9.  IR (KBr pellet): 3047 (w), 3025 (w), 2954 (m), 2856 (m), 
1609 (m), 1511 (s), 1250 (s) cm-1.  Anal. Calcd for C15H16O3: C, 73.75; H, 6.60.  Found: 
C, 73.59; H, 6.42. 
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A degassed solution of 2.54 (18 mg, 0.074 mmol) and in benzene (7.4 mL, 10.0 
mM) in a heavy-wall sealed tube (35 mL) was placed in a silicone oil bath and heated to 
230 °C.  The reaction was monitored by TLC and stopped upon consumption of starting 
material (3 h).  Concentration in vacuo, followed by medium pressure liquid 
chromatography (10-20% Et2O:hexanes) with a base-washed column (1% pyridine in 
EtOAc) was used to separate the diastereomers.  Oxepine 2.55 was obtained as a 
colorless oil in 48% yield (8.6 mg, 0.035 mmol), and oxepine 2.56 was obtained as a 
colorless oil in 23% yield (4.2 mg, 0.017 mmol). 
Oxepine 2.55:  1H-NMR (400 MHz, CDCl3): δ 7.15 (d, J = 6.8 Hz, 2H), 6.83 (d, 
J = 6.8 Hz, 2H), 6.48 (d, J = 2.0 Hz, 1H), 6.32 (d, J = 6.4 Hz), 4.91 (t, J = 6.4 Hz, 1H), 
4.18 (d, J = 9.6 Hz, 1H), 3.96 (t, J = 6.4 Hz, 1H), 3.92 (dt, J = 9.2, 1.6 Hz, 1H), 3.79 (s, 
3H), 3.64  (dd, J = 6.4, 3.2 Hz, 1H), 3.62 (m, 1H), 3.42 (dd, J = 6.8, 5.6 Hz, 1H).  13C-
NMR (100 MHz, CDCl3): δ 158.6, 142.3, 134.3, 133.6, 130.8, 121.8, 113.6, 109.3, 71.9, 
70.1, 55.4, 46.8, 45.1.  IR (NaCl thin film): 3080 (w), 3020 (w), 2949 (m), 2927 (s), 2840 
(m), 1702 (m), 1653 (m), 1609 (m), 1511 (s), 1250 (m), 1146 (m) cm-1.  EI HRMS: 
Calcd for C15H16O3 (+M): 244.1099; Found: 244.1103. 
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Oxepine 2.56:  1H-NMR (400 MHz, CDCl3): δ 7.09 (d, J = 6.8 Hz, 2H), 6.86 (d, 
J = 6.8 Hz, 2H), 6.44 (s, 1H), 6.20 (dd, J = 6.0, 2.0 Hz, 1H), 4.68 (dd, J = 6.4, 2.0 Hz, 
1H), 4.38 (s, 2H), 3.80 (s, 3H), 3.65 (t, J = 6.4 Hz, 1H), 3.46 (m, 1H), 3.23 (m, 1H).  13C-
NMR (100 MHz, CDCl3): δ 158.6, 141.0, 136.5, 135.1, 128.6, 122.2, 114.3, 111.8, 73.9, 
70.7, 55.5, 49.9, 46.3.  IR (NaCl thin film): 3031 (w), 2954 (m), 2829 (m), 1696 (m), 
1642 (s), 1511 (s), 1304 (s), 1255 (s), 1146 (s), 814 (s) cm-1.  EI HRMS: Calcd for 
C15H16O3 (+M): 244.1099; Found: 244.1102. 
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A round bottom flask (10 mL) was charged with cyclobutene VI43,45 (270 mg, 
0.875 mmol) in CH2Cl2 (2.2 mL) and m-CPBA (206 mg, 1.19 mmol).  The flask was 
flushed with N2 and allowed to stir at rt.  The consumption of starting material was 
monitored by TLC.  Upon completion (3 h), the reaction was quenched with Na2S2O3(sat. 
aq.) (3.0 mL), diluted with CH2Cl2 (3.0 mL) and allowed to stir for 1 h.  The mixture was 
diluted with CH2Cl2 (30 mL) and the organic layer was separated, washed with 
NaHCO3(sat. aq.), dried over MgSO4, filtered and concentrated in vacuo.  The resulting 
oil was purified by silica gel chromatography (2:1 hexanes:Et2O).  Epoxide 2.57 was 
obtained in 80% yield as a colorless oil (227 mg, 0.700 mmol).  
                                                
(45) Randall, M. L.; Lo, P. C. K.; Bonitatebus, P. J. Jr.; Snapper, M. L. J. Am. Chem. Soc. 1999, 12, 4534-
4535.  
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Epoxide 2.57:  1H-NMR (400 MHz, CDCl3): δ 4.05 (d, J = 2.4 Hz, 1H), 3.94 (m, 
2H), 3.71 (s, 3H), 2.88 (m, 2H), 2.51 (dd, J = 8.0, 4.0 Hz, 1H), 2.10 (m, 1H), 1.68 (m, 
3H), 0.88 (s, 9H), 0.08 (d, J = 14.8, 6H).  13C-NMR (100 MHz, CDCl3): δ 173.2, 71.2, 
63.9, 53.7, 52.0, 44.0, 41.0, 39.3, 34.7, 29.4, 26.0, 18.4, -4.6.  IR (NaCl thin film): 3028 
(w), 2954 (s), 2896 (m), 2858 (m), 1737 (s), 1472 (w), 1436 (w), 1256 (s), 1175 (m), 
1076 (m), 1052 (m), 1002 (w), 836 (m) cm-1.  EI HRMS: Calcd for C17H28O4Si (M+1): 
325.1835; Found: 325.1838. 
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A degassed solution of 2.57 (221 mg, 0.683 mmol) and BHT (226 mg, 1.02 
mmol) in benzene (68.3 mL) in a heavy-wall sealed tube (350 mL) was placed in a 
silicone oil bath and heated to 230 °C.  The reaction was monitored by TLC and stopped 
upon consumption of starting material (3 h).  Concentration in vacuo, followed by 
filtration through basic alumina (1 cm plug) eluting with hexanes to remove the BHT 
afforded oxepines 2.58 and 2.59 as a slightly yellow oil in 75% yield (166 mg, 0.512 
mmol, 1:1 ratio). 
Oxepines 2.58 & 2.59:  1H-NMR (400 MHz, CDCl3): δ 6.39 (m, 2H), 6.30 (d, J = 
7.6 Hz, 1H), 6.22 (dd, J = 8.0, 2.4 Hz, 1H), 4.75 (t, J = 8.0 Hz, 1H), 4.69 (dd, J = 7.6, 2.4 
Hz, 1H), 4.53 (m, 2H), 3.72 (s, 3H), 3.66 (s, 3H), 3.45 (dd, J = 8.4, 4.4 Hz, 1H), 3.20 (m, 
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1H), 3.12 (dt, J  = 9.2, 2.8 Hz, 1H), 3.07 (m, 1H), 1.68 (m, 8H), 0.89 (d, J = 1.6 Hz, 
18H), 0.07 (dd, J = 4.0, 2.0 Hz, 12H).  
m-CPBA, 
CH2Cl2
99%
O
H H
2.60
OBn
TBSO TBSO
OBn
VII  
A small vial was charged with cyclobutene VII46 (24 mg, 0.066 mmol) in CH2Cl2 
(0.2 mL) and m-CPBA (19 mg, 0.11 mmol).  The flask was flushed with N2 and allowed 
to stir at rt.  The consumption of starting material was monitored by TLC.  Upon 
completion (1.5 h), the reaction was quenched with Na2S2O3(sat. aq.) (1.0 mL), diluted 
with CH2Cl2 (1.0 mL) and allowed to stir for 1 h.  The mixture was diluted with CH2Cl2 
(30 mL) and the organic layer was separated, washed with NaHCO3(sat. aq.), dried over 
MgSO4, filtered and concentrated in vacuo.  The resulting oil was purified by silica gel 
chromatography (2:1 hexanes:Et2O).  Epoxide 2.60 was obtained in 99% yield as a 
colorless oil (25 mg, 0.65 mmol).  
Epoxide 2.60:  1H-NMR (400 MHz, CDCl3): δ 7.34 (m, 5H), 4.53 (q, J = 12.4 
Hz, 2H), 3.92 (m, 2H), 3.87 (d, J = 2.0 Hz, 1H), 3.57 (m, 2H), 2.34 (m, 3H), 2.02 (m, 
1H), 1.71 (m, 2H), 1.52 (m, 1H), 0.88 (s, 9H), 0.07 (d, J = 14.4 Hz, 6H).  13C-NMR (100 
MHz, CDCl3): δ 138.4, 128.5, 127.7, 73.2, 71.6, 71.4, 63.7, 54.5, 52.0, 44.3, 38.3, 38.1, 
34.9, 29.6, 26.1, 18.5, -4.5.  IR (NaCl thin film): 3048 (w), 2954 (s), 2885 (w), 2859 (m), 
                                                
(46) Deak, H. L.; Williams, M. J.; Snapper, M. L. Org. Lett. 2005, 7, 5785-5788. 
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1471 (w), 1362 (w), 1255 (m), 1059 (m) cm-1.   EI HRMS: Calcd for C23H34O3Si(+M): 
386.2277; Found: 386.2274. 
230 °C, 
6 h
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(23%)  
A degassed solution of 2.60 (25.2 mg, 0.0652 mmol) in benzene (6.5 mL) in a 
heavy-wall sealed tube (35 mL) was placed in a silicone oil bath and heated to 230 °C.  
The reaction was monitored by TLC and stopped upon consumption of starting material 
(3 h).  Concentration in vacuo, followed by medium pressure liquid chromatography (5% 
CH2Cl2:hexanes) with a base-washed column (1% pyridine in EtOAc) was used to 
separate the diastereomers. Oxepine 2.62 was obtained as a colorless oil in 32% yield 
(8.1 mg, 0.021 mmol), and oxepine 2.63 was obtained as a colorless oil in 23% yield (5.9 
mg, 0.015 mmol). 
Oxepine 2.62:  1H-NMR (400 MHz, CDCl3): δ 7.31 (m, 5H), 6.35 (t, J = 2.0 Hz, 
1H), 6.17 (dd, J = 8.0, 2.4 Hz, 1H), 4.73 (dd, J = 8.0, 2.4 Hz, 1H), 4.52 (m, 3H), 3.49 (dd, 
J = 9.2, 3.6 Hz, 1H), 3.31 (dd, J = 9.2, 7.2 Hz, 1H), 2.94 (m, 1H), 2.41 (m, 1H), 1.92 (m, 
2H), 1.54 (m, 1H), 1.24 (m, 2H), 0.90 (s, 9H), 0.08 (d, J = 3.2 Hz, 6H).  13C-NMR (100 
MHz, CD3OD): δ 142.4, 140.0, 129.3, 128.8, 128.5, 110.3, 76.6, 74.2, 73.5, 44.7, 44.3, 
36.5, 29.1, 26.5, 19.2, -4.0, -4.3.  IR (NaCl thin film): 3087 (w), 3037 (w), 2955 (s), 2860 
(s), 1684 (w), 1653 (m), 1471 (w), 1361 (m), 1254 (m), 1195 (m), 1115 (s), 866 (m), 837 
(m), 426 (m) cm-1. EI HRMS: Calcd for C23H34O3Si(+M): 386.2277; Found: 386.2277. 
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Oxepine 2.63:  1H-NMR (400 MHz, CDCl3): δ 7.30 (m, 5H), 6.34 (d, J = 2.4 Hz, 
1H), 6.15 (d, J = 8.0 Hz, 1H), 4.96 (t, J = 8.0 Hz, 1H), 4.94 (m, 3H), 3.74 (dd, J = 8.8, 5.2 
Hz, 1H), 3.46 (t, J = 8.0 Hz, 1H), 3.10 (m, 1H), 2.77 (m, 1H), 1.90 (m, 1H), 1.70 (m, 2H), 
1.55 (m, 1H), 0.89 (s, 9H), 0.07 (d, J = 3.2 Hz, 6H).  13C-NMR (100 MHz, CDCl3): δ 
141.8, 138.7, 137.9, 128.4, 127.6, 127.5, 126.0, 110.1, 75.3, 74.5, 73.4, 43.7, 42.1, 36.4, 
27.3, 26.2, 18.4, -4.1.  IR (NaCl thin film): 3060 (m), 3028 (s), 2954 (s), 2921 (s), 2859 
(s), 1682 (m), 1649 (m), 1462 (w), 1331 (w), 1255 (m), 1183 (m), 1129 (m), 1092 (m), 
1037 (m), 835 (m) cm-1.  EI HRMS: Calcd for C23H34O3Si (+M): 386.2277; Found: 
386.2280.   
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A round bottom flask (10 mL) was charged with epoxide 2.42 (110 mg, 0.523 
mmol) in CH2Cl2 (1.0 mL).  t-Butyldimethylsilylchloride (118 mg, 0.785 mmol) and 
imidazole (57.0 mg, 0.837 mmol) were added to the solution, which was then flushed 
with N2 and allowed to stir at rt.  The consumption of starting material was monitored by 
TLC.  Upon completion (24 h), the reaction was quenched with NH4Cl(sat. aq.) (1.0 mL) 
and diluted with hexanes (4.0 mL).  The organic layer was separated, washed with 
NaCl(sat. aq.), dried over MgSO4, filtered and concentrated in vacuo.  The resulting oil 
was purified by silica gel chromatography (4:1 hexanes:Et2O).  Epoxide 2.63 was 
obtained in 66% yield (113 mg, 0.348 mmol) as a colorless oil.  
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Epoxide 2.63:  1H-NMR (400 MHz, CDCl3): δ 4.07 (m, 1H), 3.99 (d, J = 2.0 Hz, 
1H), 3.82 (dd, J = 3.2, 2.0 Hz, 1H), 3.71 (s, 3H), 3.01 (dd, J = 8.0, 5.6 Hz, 1H), 2.91 (dd, 
J = 8.0, 3.2 Hz, 1H), 2.73 (m, 1H), 1.89 (m, 1H), 1.69 (m, 3H), 0.88 (s, 9H), 0.08 (d, J = 
4.8 Hz, 6H).  13C-NMR (100 MHz, CDCl3): δ 173.3, 73.6, 61.2, 54.8, 51.9, 51.7, 42.2, 
41.9, 39.5, 35.2, 28.0, 26.2, 18.7, -4.7.  IR (NaCl thin film): 2954 (s), 2886 (m), 2859 
(m), 1737 (s), 1471 (w), 1437 (w), 1365 (w), 1255 (m), 1122 (m), 865 (m), 837 (m), 779 
(w), 431 (m) cm-1.  EI HRMS: Calcd for C17H28O4Si (M+1): 325.1835; Found: 325.1829.   
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A degassed solution of 2.63 (32.5 mg, 0.100 mmol) and BHT (44.0 mg, 0.200 
mmol) in benzene (10.0 mL) in a heavy-wall sealed tube (35 mL) was placed in a silicone 
oil bath and heated to 220 °C.  The reaction was monitored by TLC and stopped upon 
consumption of starting material (5 h).  Concentration in vacuo, followed by filtration 
through basic alumina (1 cm plug) eluting with hexanes to remove the BHT afforded 
oxepines 2.64 and 2.65 as a slightly yellow oil in 72% yield (23.4 mg, 0.0721 mmol, 1:3 
ratio). 
Oxepines 2.64 & 2.65:  1H-NMR (400 MHz, CDCl3): δ 6.40 (m, 2H), 6.28 (d, J = 
8.0 Hz, 1H), 6.22 (dd, J = 7.6, 2.8 Hz, 1H), 4.77 (m, 1H), 4.74 (t, J = 8.0 Hz, 1H), 4.67 
(dd, J = 8.0, 2.8 Hz, 1H), 4.51 (t, J = 4.4 Hz, 1H), 3.73 (s, 3H), 3.67 (s, 3H), 3.40 (dd, J = 
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8.4, 3.6 Hz, 1H), 3.26 (dt, J = 9.2, 2.8 Hz, 1H), 3.21 (m, 1H), 3.02 (m, 1H), 1.68 (m, 8H), 
0.90 (s, 9H), 0.88 (d, J = 2.0 Hz, 9H), 0.01 (d, J = 4.8 Hz, 6H), 0.07 (s, 6H). 
 
 
 
 
X-ray Crystal Structure of Epoxide 2.24 
 
Table 1.  Crystal data and structure refinement for Compound 2.24. 
Identification code  ajl01t 
Empirical formula  C10 H12 O4 
Formula weight  196.20 
 66 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 6.0680(6) Å a= 90°. 
 b = 10.6903(10) Å b= 92.640(2)°. 
 c = 14.2193(14) Å g = 90°. 
Volume 921.41(15) Å3 
Z 4 
Density (calculated) 1.414 Mg/m3 
Absorption coefficient 0.110 mm-1 
F(000) 416 
Crystal size 0.60 x 0.10 x 0.10 mm3 
Theta range for data collection 2.38 to 28.28°. 
Index ranges -6<=h<=8, -14<=k<=13, -18<=l<=15 
Reflections collected 6682 
Independent reflections 2283 [R(int) = 0.0504] 
Completeness to theta = 28.28° 99.8%  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2283 / 0 / 127 
Goodness-of-fit on F2 1.004 
Final R indices [I>2sigma(I)] R1 = 0.0472, wR2 = 0.1265 
R indices (all data) R1 = 0.0578, wR2 = 0.1318 
Largest diff. peak and hole 0.415 and -0.315 e.Å-3 
 
Table 2.  Atomic coordinates  (x 104) and equivalent isotropic displacement parameters (Å2x 103) 
For Compound 2.24.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(2) 2330(2) 4744(1) 4074(1) 35(1) 
O(1) 5821(2) 8076(1) 3035(1) 39(1) 
O(4) -1515(2) 6142(1) 1082(1) 35(1) 
C(7) 3525(2) 5889(1) 4229(1) 29(1) 
C(3) 3964(2) 6327(1) 2361(1) 24(1) 
C(6) 2993(2) 6633(1) 3351(1) 23(1) 
C(9) 689(2) 6175(1) 2977(1) 27(1) 
C(2) 1693(2) 5810(1) 2033(1) 23(1) 
O(3) 1657(2) 6729(1) 495(1) 52(1) 
C(1) 654(2) 6294(1) 1124(1) 26(1) 
C(5) 3499(2) 7994(1) 3196(1) 32(1) 
C(4) 4327(2) 7728(1) 2258(1) 30(1) 
C(8) 236(3) 5102(2) 3647(1) 38(1) 
C(10) -2670(3) 6565(2) 225(1) 39(1) 
________________________________________________________________________________   
 
Table 3.   Bond lengths [Å] and angles [°] for Compound 2.24. 
_____________________________________________________  
O(2)-C(7)  1.4344(17) 
O(2)-C(8)  1.4347(18) 
O(1)-C(5)  1.4400(19) 
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O(1)-C(4)  1.4442(16) 
O(4)-C(1)  1.3248(16) 
O(4)-C(10)  1.4494(15) 
C(7)-C(6)  1.5024(17) 
C(3)-C(4)  1.5219(18) 
C(3)-C(2)  1.5372(17) 
C(3)-C(6)  1.5849(18) 
C(6)-C(5)  1.5055(18) 
C(6)-C(9)  1.5519(17) 
C(9)-C(8)  1.525(2) 
C(9)-C(2)  1.5490(18) 
C(2)-C(1)  1.5041(17) 
O(3)-C(1)  1.1987(17) 
C(5)-C(4)  1.474(2) 
 
C(7)-O(2)-C(8) 105.61(10) 
C(5)-O(1)-C(4) 61.47(9) 
C(1)-O(4)-C(10) 116.13(11) 
O(2)-C(7)-C(6) 103.69(10) 
C(4)-C(3)-C(2) 117.17(10) 
C(4)-C(3)-C(6) 86.78(10) 
C(2)-C(3)-C(6) 88.82(9) 
C(7)-C(6)-C(5) 126.60(11) 
C(7)-C(6)-C(9) 105.87(10) 
C(5)-C(6)-C(9) 116.18(11) 
C(7)-C(6)-C(3) 123.63(11) 
C(5)-C(6)-C(3) 89.00(10) 
C(9)-C(6)-C(3) 89.76(9) 
C(8)-C(9)-C(2) 116.16(12) 
C(8)-C(9)-C(6) 102.04(10) 
C(2)-C(9)-C(6) 89.60(10) 
C(1)-C(2)-C(3) 118.15(11) 
C(1)-C(2)-C(9) 119.48(11) 
C(3)-C(2)-C(9) 91.66(9) 
O(3)-C(1)-O(4) 123.46(12) 
O(3)-C(1)-C(2) 124.61(12) 
O(4)-C(1)-C(2) 111.88(11) 
O(1)-C(5)-C(4) 59.41(9) 
O(1)-C(5)-C(6) 106.82(11) 
C(4)-C(5)-C(6) 91.52(11) 
O(1)-C(4)-C(5) 59.13(9) 
O(1)-C(4)-C(3) 105.54(10) 
C(5)-C(4)-C(3) 92.63(10) 
O(2)-C(8)-C(9) 106.46(11) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (Å2x 103) for Compound 2.24.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
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O(2) 45(1)  29(1) 30(1)  8(1) -1(1)  -6(1) 
O(1) 38(1)  35(1) 42(1)  3(1) -6(1)  -12(1) 
O(4) 27(1)  53(1) 25(1)  7(1) -2(1)  -2(1) 
C(7) 33(1)  29(1) 25(1)  4(1) -2(1)  -1(1) 
C(3) 23(1)  25(1) 24(1)  2(1) 2(1)  2(1) 
C(6) 25(1)  23(1) 22(1)  1(1) 0(1)  2(1) 
C(9) 24(1)  34(1) 22(1)  3(1) 3(1)  2(1) 
C(2) 25(1)  23(1) 23(1)  2(1) 1(1)  0(1) 
O(3) 35(1)  84(1) 35(1)  27(1) 1(1)  -6(1) 
C(1) 28(1)  26(1) 23(1)  1(1) 2(1)  0(1) 
C(5) 38(1)  25(1) 32(1)  1(1) -1(1)  1(1) 
C(4) 31(1)  29(1) 30(1)  6(1) -1(1)  -4(1) 
C(8) 36(1)  51(1) 28(1)  9(1) 2(1)  -14(1) 
C(10) 36(1)  52(1) 29(1)  3(1) -8(1)  5(1) 
______________________________________________________________________________  
 
Table 5.   Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 10 3) 
for Compound 2.24. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(7A) 5130 5730 4309 35 
H(7B) 3024 6330 4793 35 
H(3A) 5272 5760 2344 29 
H(9A) -479 6835 2929 32 
H(2A) 1788 4877 1997 28 
H(5A) 2527 8712 3355 38 
H(4A) 4010 8231 1675 36 
H(8A) -776 5376 4133 46 
H(8B) -447 4389 3297 46 
H(10A) -4254 6413 268 59 
H(10B) -2124 6106 -314 59 
H(10C) -2411 7462 141 59 
________________________________________________________________________________  
 
Table 6.  Torsion angles [°] for Compound 2.24. 
________________________________________________________________  
C(8)-O(2)-C(7)-C(6) -40.78(14) 
O(2)-C(7)-C(6)-C(5) 169.19(13) 
O(2)-C(7)-C(6)-C(9) 27.69(14) 
O(2)-C(7)-C(6)-C(3) -72.91(15) 
C(4)-C(3)-C(6)-C(7) -136.79(12) 
C(2)-C(3)-C(6)-C(7) 105.92(12) 
C(4)-C(3)-C(6)-C(5) -1.99(10) 
C(2)-C(3)-C(6)-C(5) -119.28(10) 
C(4)-C(3)-C(6)-C(9) 114.20(9) 
C(2)-C(3)-C(6)-C(9) -3.09(9) 
C(7)-C(6)-C(9)-C(8) -5.30(14) 
C(5)-C(6)-C(9)-C(8) -151.46(13) 
C(3)-C(6)-C(9)-C(8) 119.77(11) 
C(7)-C(6)-C(9)-C(2) -122.01(11) 
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C(5)-C(6)-C(9)-C(2) 91.83(13) 
C(3)-C(6)-C(9)-C(2) 3.07(9) 
C(4)-C(3)-C(2)-C(1) 42.35(16) 
C(6)-C(3)-C(2)-C(1) 128.12(11) 
C(4)-C(3)-C(2)-C(9) -82.67(12) 
C(6)-C(3)-C(2)-C(9) 3.10(9) 
C(8)-C(9)-C(2)-C(1) 129.65(12) 
C(6)-C(9)-C(2)-C(1) -127.11(11) 
C(8)-C(9)-C(2)-C(3) -106.40(11) 
C(6)-C(9)-C(2)-C(3) -3.16(9) 
C(10)-O(4)-C(1)-O(3) -1.4(2) 
C(10)-O(4)-C(1)-C(2) -179.20(11) 
C(3)-C(2)-C(1)-O(3) 24.6(2) 
C(9)-C(2)-C(1)-O(3) 134.49(15) 
C(3)-C(2)-C(1)-O(4) -157.62(11) 
C(9)-C(2)-C(1)-O(4) -47.74(16) 
C(4)-O(1)-C(5)-C(6) 81.57(11) 
C(7)-C(6)-C(5)-O(1) 76.25(17) 
C(9)-C(6)-C(5)-O(1) -145.60(11) 
C(3)-C(6)-C(5)-O(1) -56.36(11) 
C(7)-C(6)-C(5)-C(4) 134.66(13) 
C(9)-C(6)-C(5)-C(4) -87.19(13) 
C(3)-C(6)-C(5)-C(4) 2.05(10) 
C(5)-O(1)-C(4)-C(3) -83.64(11) 
C(6)-C(5)-C(4)-O(1) -108.70(10) 
O(1)-C(5)-C(4)-C(3) 106.56(10) 
C(6)-C(5)-C(4)-C(3) -2.14(10) 
C(2)-C(3)-C(4)-O(1) 147.68(11) 
C(6)-C(3)-C(4)-O(1) 60.67(11) 
C(2)-C(3)-C(4)-C(5) 89.04(13) 
C(6)-C(3)-C(4)-C(5) 2.03(10) 
C(7)-O(2)-C(8)-C(9) 38.09(15) 
C(2)-C(9)-C(8)-O(2) 76.46(14) 
C(6)-C(9)-C(8)-O(2) -19.09(15) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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X-ray Crystal Structure of Compound 2.28 
 
Table 1.  Crystal data and structure refinement for Compound 2.28. 
Identification code  ajl02t 
 71 
Empirical formula  C14 H13 N2 O8 
Formula weight  337.26 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 10.7652(15) Å a= 90°. 
 b = 5.7780(9) Å b= 96.903(4)°. 
 c = 25.226(4) Å g = 90°. 
Volume 1557.7(4) Å3 
Z 4 
Density (calculated) 1.438 Mg/m3 
Absorption coefficient 0.120 mm-1 
F(000) 700 
Crystal size 0.3 x 0.2 x 0.2 mm3 
Theta range for data collection 1.63 to 22.50°. 
Index ranges -11<=h<=11, -6<=k<=6, -20<=l<=27 
Reflections collected 6771 
Independent reflections 2030 [R(int) = 0.0409] 
Completeness to theta = 22.50° 100.0%  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2030 / 0 / 235 
Goodness-of-fit on F2 1.060 
Final R indices [I>2sigma(I)] R1 = 0.0956, wR2 = 0.2628 
R indices (all data) R1 = 0.1077, wR2 = 0.2731 
Largest diff. peak and hole 1.307 and -0.355 e.Å-3 
 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for Compound 2.28.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(4) 6026(4) 10477(7) 446(2) 61(1) 
O(8) 2831(4) 4448(8) 19(2) 65(1) 
C(15) 4166(5) 4411(10) 804(2) 44(1) 
C(11) 5775(5) 7211(9) 990(2) 38(1) 
C(12) 6165(5) 6119(9) 1476(2) 41(1) 
C(16) 4758(5) 6375(9) 653(2) 39(1) 
C(14) 4517(5) 3274(10) 1281(2) 46(1) 
N(17) 5925(5) 2994(9) 2116(2) 58(1) 
O(1) 10939(4) 11600(8) 2403(2) 69(1) 
C(10) 6446(5) 9251(10) 802(2) 42(1) 
O(5) 6841(4) 3737(8) 2389(2) 65(1) 
N(18) 3134(4) 3428(9) 443(2) 53(1) 
O(3) 7545(4) 9569(8) 1083(2) 73(2) 
C(13) 5513(5) 4182(10) 1603(2) 46(1) 
O(2) 11649(4) 6292(8) 1059(2) 71(1) 
O(7) 2646(4) 1669(9) 577(2) 75(2) 
C(4) 11419(5) 9247(11) 1702(2) 52(2) 
 72 
C(1) 10075(6) 9997(13) 1600(3) 75(2) 
O(6) 5312(5) 1364(9) 2230(2) 93(2) 
C(6) 10648(7) 6950(13) 730(3) 67(2) 
C(2) 9985(7) 12174(11) 2011(3) 69(2) 
C(5) 12114(6) 7739(12) 1472(2) 64(2) 
C(8) 9644(5) 10705(10) 1049(2) 51(2) 
C(7) 9833(8) 8554(16) 673(3) 89(3) 
C(3) 11934(8) 10710(17) 2156(3) 93(3) 
C(9) 8342(6) 11382(14) 899(4) 95(3) 
________________________________________________________________________________  
 
Table 3.   Bond lengths [Å] and angles [°] for  Compound IX 
_____________________________________________________  
O(4)-C(10)  1.191(6) 
O(8)-N(18)  1.230(6) 
C(15)-C(16)  1.377(7) 
C(15)-C(14)  1.384(8) 
C(15)-N(18)  1.465(7) 
C(11)-C(16)  1.390(7) 
C(11)-C(12)  1.397(7) 
C(11)-C(10)  1.489(8) 
C(12)-C(13)  1.380(7) 
C(14)-C(13)  1.370(8) 
N(17)-O(6)  1.204(7) 
N(17)-O(5)  1.211(6) 
N(17)-C(13)  1.484(8) 
O(1)-C(2)  1.379(8) 
O(1)-C(3)  1.401(8) 
C(10)-O(3)  1.316(6) 
N(18)-O(7)  1.210(6) 
O(3)-C(9)  1.464(7) 
O(2)-C(6)  1.333(8) 
O(2)-C(5)  1.382(8) 
C(4)-C(5)  1.328(9) 
C(4)-C(3)  1.476(10) 
C(4)-C(1)  1.502(9) 
C(1)-C(8)  1.471(9) 
C(1)-C(2)  1.640(10) 
C(6)-C(7)  1.273(11) 
C(8)-C(9)  1.460(9) 
C(8)-C(7)  1.591(11) 
 
C(16)-C(15)-C(14) 123.0(5) 
C(16)-C(15)-N(18) 119.3(5) 
C(14)-C(15)-N(18) 117.6(5) 
C(16)-C(11)-C(12) 120.7(5) 
C(16)-C(11)-C(10) 117.2(5) 
C(12)-C(11)-C(10) 122.0(5) 
C(13)-C(12)-C(11) 117.6(5) 
C(15)-C(16)-C(11) 118.3(5) 
C(13)-C(14)-C(15) 116.5(5) 
O(6)-N(17)-O(5) 125.0(5) 
 73 
O(6)-N(17)-C(13) 117.0(6) 
O(5)-N(17)-C(13) 118.0(5) 
C(2)-O(1)-C(3) 108.2(5) 
O(4)-C(10)-O(3) 123.9(5) 
O(4)-C(10)-C(11) 123.8(5) 
O(3)-C(10)-C(11) 112.3(5) 
O(7)-N(18)-O(8) 124.5(5) 
O(7)-N(18)-C(15) 118.3(5) 
O(8)-N(18)-C(15) 117.2(5) 
C(10)-O(3)-C(9) 117.0(5) 
C(14)-C(13)-C(12) 123.8(5) 
C(14)-C(13)-N(17) 118.1(5) 
C(12)-C(13)-N(17) 118.1(5) 
C(6)-O(2)-C(5) 119.3(6) 
C(5)-C(4)-C(3) 122.4(6) 
C(5)-C(4)-C(1) 134.1(6) 
C(3)-C(4)-C(1) 103.4(6) 
C(8)-C(1)-C(4) 115.5(6) 
C(8)-C(1)-C(2) 110.4(6) 
C(4)-C(1)-C(2) 104.0(5) 
C(7)-C(6)-O(2) 140.5(8) 
O(1)-C(2)-C(1) 100.0(5) 
C(4)-C(5)-O(2) 123.7(6) 
C(9)-C(8)-C(1) 120.2(6) 
C(9)-C(8)-C(7) 104.1(6) 
C(1)-C(8)-C(7) 107.3(5) 
C(6)-C(7)-C(8) 129.7(7) 
O(1)-C(3)-C(4) 108.6(6) 
O(3)-C(9)-C(8) 107.9(5) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (Å2x 103) for Compound 2.28.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(4) 57(3)  56(2) 64(3)  20(2) -15(2)  -15(2) 
O(8) 66(3)  75(3) 53(3)  -8(2) 0(2)  -20(2) 
C(15) 40(3)  49(3) 44(3)  -6(3) 9(2)  -5(3) 
C(11) 32(3)  38(3) 44(3)  3(2) 6(2)  4(2) 
C(12) 37(3)  39(3) 47(3)  3(3) 8(2)  5(2) 
C(16) 39(3)  44(3) 35(3)  -1(2) 8(2)  0(2) 
C(14) 43(3)  43(3) 55(4)  1(3) 12(3)  -5(3) 
N(17) 59(3)  56(3) 61(3)  15(3) 10(3)  7(3) 
O(1) 55(3)  83(3) 67(3)  -24(3) -6(2)  11(2) 
C(10) 33(3)  48(3) 44(3)  5(3) -1(2)  2(3) 
O(5) 62(3)  69(3) 60(3)  13(2) -9(2)  -1(2) 
N(18) 51(3)  57(3) 53(3)  -10(3) 9(2)  -16(3) 
O(3) 37(2)  92(3) 85(3)  50(3) -19(2)  -21(2) 
C(13) 49(3)  45(3) 47(3)  4(3) 13(3)  8(3) 
O(2) 66(3)  84(3) 61(3)  -18(3) 4(2)  18(3) 
 74 
O(7) 81(3)  72(3) 73(3)  -4(2) 7(2)  -42(3) 
C(4) 38(3)  59(4) 60(4)  6(3) 8(3)  12(3) 
C(1) 60(4)  71(5) 91(5)  19(4) -1(4)  -7(4) 
O(6) 95(4)  83(4) 95(4)  49(3) -9(3)  -28(3) 
C(6) 60(4)  62(4) 74(5)  5(4) -8(4)  1(4) 
C(2) 72(4)  41(3) 96(5)  -8(3) 15(4)  -9(3) 
C(5) 64(4)  74(4) 50(4)  5(3) -11(3)  -18(4) 
C(8) 37(3)  50(3) 63(4)  18(3) -7(3)  -10(3) 
C(7) 91(6)  115(7) 58(4)  4(5) -8(4)  -35(6) 
C(3) 80(5)  122(7) 76(5)  -16(5) 2(4)  41(5) 
C(9) 40(4)  99(6) 138(7)  73(6) -13(4)  -20(4) 
______________________________________________________________________________  
 
Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for Compound 2.28. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(12A) 6855 6689 1710 49 
H(16A) 4479 7137 326 47 
H(14A) 4089 1933 1380 55 
H(1A) 9530 8711 1703 90 
H(6A) 10494 5870 446 80 
H(2A) 10142 13673 1841 83 
H(2B) 9165 12226 2151 83 
H(5A) 12980 7648 1598 77 
H(8A) 10192 11995 951 61 
H(7A) 9250 8452 360 107 
H(3A) 12492 9781 2414 112 
H(3B) 12428 11994 2027 112 
H(9A) 8172 12878 1068 113 
H(9B) 8170 11559 507 113 
________________________________________________________________________________   
 
Table 6.  Torsion angles [°] for Compound IX. 
________________________________________________________________  
C(16)-C(11)-C(12)-C(13) 0.6(7) 
C(10)-C(11)-C(12)-C(13) -177.3(5) 
C(14)-C(15)-C(16)-C(11) 1.8(8) 
N(18)-C(15)-C(16)-C(11) -176.9(5) 
C(12)-C(11)-C(16)-C(15) -1.6(7) 
C(10)-C(11)-C(16)-C(15) 176.4(4) 
C(16)-C(15)-C(14)-C(13) -0.9(8) 
N(18)-C(15)-C(14)-C(13) 177.8(5) 
C(16)-C(11)-C(10)-O(4) 16.2(8) 
C(12)-C(11)-C(10)-O(4) -165.8(5) 
C(16)-C(11)-C(10)-O(3) -165.1(5) 
C(12)-C(11)-C(10)-O(3) 12.9(7) 
C(16)-C(15)-N(18)-O(7) 178.2(5) 
C(14)-C(15)-N(18)-O(7) -0.5(8) 
C(16)-C(15)-N(18)-O(8) -1.1(7) 
 75 
C(14)-C(15)-N(18)-O(8) -179.8(5) 
O(4)-C(10)-O(3)-C(9) -7.4(9) 
C(11)-C(10)-O(3)-C(9) 173.9(6) 
C(15)-C(14)-C(13)-C(12) -0.2(8) 
C(15)-C(14)-C(13)-N(17) -179.4(5) 
C(11)-C(12)-C(13)-C(14) 0.3(8) 
C(11)-C(12)-C(13)-N(17) 179.5(4) 
O(6)-N(17)-C(13)-C(14) -3.7(8) 
O(5)-N(17)-C(13)-C(14) 176.7(5) 
O(6)-N(17)-C(13)-C(12) 177.1(5) 
O(5)-N(17)-C(13)-C(12) -2.5(8) 
C(5)-C(4)-C(1)-C(8) -51.8(10) 
C(3)-C(4)-C(1)-C(8) 126.3(7) 
C(5)-C(4)-C(1)-C(2) -172.9(7) 
C(3)-C(4)-C(1)-C(2) 5.3(7) 
C(5)-O(2)-C(6)-C(7) -6.4(14) 
C(3)-O(1)-C(2)-C(1) 39.4(7) 
C(8)-C(1)-C(2)-O(1) -151.2(5) 
C(4)-C(1)-C(2)-O(1) -26.8(6) 
C(3)-C(4)-C(5)-O(2) 177.7(7) 
C(1)-C(4)-C(5)-O(2) -4.4(12) 
C(6)-O(2)-C(5)-C(4) 27.8(9) 
C(4)-C(1)-C(8)-C(9) 177.6(6) 
C(2)-C(1)-C(8)-C(9) -64.8(8) 
C(4)-C(1)-C(8)-C(7) 59.2(7) 
C(2)-C(1)-C(8)-C(7) 176.8(5) 
O(2)-C(6)-C(7)-C(8) -2.7(16) 
C(9)-C(8)-C(7)-C(6) -158.8(8) 
C(1)-C(8)-C(7)-C(6) -30.4(10) 
C(2)-O(1)-C(3)-C(4) -39.3(8) 
C(5)-C(4)-C(3)-O(1) -163.4(6) 
C(1)-C(4)-C(3)-O(1) 18.2(8) 
C(10)-O(3)-C(9)-C(8) -150.0(6) 
C(1)-C(8)-C(9)-O(3) -50.5(10) 
C(7)-C(8)-C(9)-O(3) 69.5(8) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Chapter 3:  Development of a flexible synthetic strategy for the 
synthesis of guaiane natural products 
 
3.1 Introduction 
 The guaiane class of natural products represents a functionally diverse group of 
sesquiterpenes that display varying stereochemistry, complexity, and levels of oxidation 
(Figure 3.1).47  While members of this class of natural products have been known since 
the early twentieth century, little has been reported about their biological activity.  Only 
recently has it been discovered that guaiol (3.9), one of simplest guaiane natural products, 
has activity against a broad range of gram-positive bacteria.48  Torilin (3.5), a more 
functionalized guaiane natural product, has been reported to posses anti-angiogenic 
activity in tumor cells.49  These recent reports of biological activity warrant cause for a 
new method to synthesize guaiane natural products.  Ideally, this method would be very 
functional group tolerant and would allow for construction of any desired guaiane natural 
product. 
                                                
(40) For a compilation of guaiane natural products, see: Connoly, J. D.; Hill, R. A. Dictionary of 
Terpenoids; 1st Edition; Chapman & Hall: Cambridge, U. K., 1991; volume 1, 465-476. 
(41) Choudhary, M. I.; Batool, I.; Atif, M.; Hussain, S.; Rahman, A.-u. J. Nat. Prod. 2007, 70, 849-852. 
(49) For relevant papers on the biological activity of torilin, see: (a) Kim, M. S.; Lee, Y. M.; Moon, E.-J.; 
Kim, S. E.; Lee, J. J.; Kim, K.-W. Int. J. Cancer 2000, 87, 269-275; (b) Park, W. S.; Son, E. D.; Nam, G. 
W.; Kim, S. H.; Noh, M. S.; Lee, B. G.; Jang, I. S.; Kim, S. E.; Lee, J. J.; Lee, C. H. Planta Med. 2003, 69, 
459-461; (c) Oh, H.; Kim, J.-S.; Song, E.-K.; Cho, H.; Kim, D.-H.; Park, S.-E.; Lee, H.-S.; Kim, Y.-C. 
Planta Med. 2002, 68, 748-749; (d) Kim, S. E.; Kim, Y. H.; Kim, Y. C., Lee, J. J. Planta Med. 1998, 64, 
332-334. 
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3.2 Background 
Recently our laboratories reported the first total syntheses of the guaiane natural 
products pleocarpenene and pleocarpenone.50  These syntheses showcased the utility of 
our cyclopropanation/thermal fragmentation methodology for the construction of 5-7 ring 
systems.  One of the key developments made in this synthetic endeavor was a copper 
catalyzed, EDA-mediated stereoselective cyclopropanation of our cyclobutene substrates.  
This cyclopropanation showed excellent diastereoselectivity and allowed for the 
installation of an additional functional group (Scheme 3.1).51  The location of this 
additional functionality at C7 is key for a versatile and efficient preparation of guaiane 
natural products.   
H
AcO
OTIPS
(i)EDA
Cu(acac)2
CH2Cl2
 reflux
(ii) EtOH, 
NaOEt
95 %
H
HO
OTIPS
EtO2CH H
3.1
Me
Me
OH
HO Me
H
H
 pleocarpenene
3.3
Me
Me
OH
O
HO Me
H
H
 pleocarpenone
3.4
3.2
Scheme 3.1:  Cyclopropanation used in the total synthesis of pleocarpenene (3.3)
 and pleocarpenone (3.4)
10
4
7
10
4
7
10
4
7
10
4
 
                                                
(50) Williams, M. J.; Deak, H. L.; Snapper, M. L. J. Am. Chem. Soc. 2007, 129, 486-487. 
(51) For a discussion regarding development of this cyclopropanation method see:  Williams, M. J.  The 
Development of New Methods Toward Guaiane Natural Products.  Ph.D. Dissertation, Boston College, 
Chestnut Hill, MA, 2007. 
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With the development of this new cyclopropanation method, we now had means 
of installing functionality with stereocontrol at the C4, C7, and C10 positions of the 
guaiane natural product skeleton.  As shown in Figure 3.1, all guaiane natural products 
contain functionality at the C4, C7, and C10 positions.  Armed with this new 
cyclopropanation, we felt that our methodology could offer a common platform to 
synthesize any guaiane natural product.  In order to highlight this concept, we chose to 
synthesize several guaiane natural products employing one divergent synthetic route.52  
3.3 Retrosynthetic analysis 
The guaiane natural products we chose to investigate, shown boxed in Figure 3.1, 
are pleocarpenene (3.3)53, pleocarpenone (3.4)53, bulnesol (3.6)54, hanamyol (3.7)55, and 
11-hydroxypogostol (3.11)56.  The retrosynthetic analysis for these natural products 
appears in Scheme 3.2.  We believe that hanamyol (3.7) can be derived from bulnesol 
(3.6) by an epoxidation of the tetra-substituted olefin, followed by intramolecular 
opening of the oxirane with the tertiary alcohol.  This transformation has been suggested 
in the literature as the biogenetic pathway.57  Bulnesol (3.6) could be accessed by an 
olefin isomerization applied to exocyclic olefin 3.15, which could be derived from 
                                                
(52) This work began in collaboration with Dr. Michael J. Williams formerly of the Snapper group. 
(53) (a) Bhakuni, D. S.; Bittner, M.; Marticorena, C.; Silva, M.; Weldt, E.; Hoeneisen, M.; Hartwell, J. L. 
Lloydia 1976, 39, 225-243; (b) Taira, Z.; Watson, W. H.; Silva, M.; Sammes, P. G. Cryst. Struct. Comm. 
1976, 5, 601-604; (c) Silva, M.; Wiesenfeld, A.; Sammes, P. G.; Tyler, T. W. Phytochemistry 1977, 16, 
379-385; (d) Gopalakrishna, E. M.; Watson, W. H.; Silva, M. Cryst. Struct. Comm. 1977, 6, 655-659; (e) 
De Pascual-T. J.; Bellido, I. S.; González, M. S. Tetrahedron 1980, 36, 371-376; (f) Zdero, C.; Bohlmann, 
F.; Niemeyer, H. M. J. Nat. Prod. 1988, 51, 509-512. 
(54) For isolation, see: (a) H. Wienhaus, H.; Scholz, H. Ber. Schimmel 1929, 269-282; (b) Dolejs, L.; 
Mironov, A.; Sorm, F. Tetrahedron Lett. 1960, 32, 18-21; Teisseire, P.; Maupetit, P.; Corbier, B. 
Recherches 1974, 19, 8-35.  For total synthesis, see: Heathcock, C. H.; Ratcliffe, R. J. Am. Chem. Soc. 
1971, 93, 1746-1757. 
(55) Itokawa, H.; Morita, H.; Watanabe, K.; Takase, A.; Iitaka, Y. Chem. Lett. 1984, 1687. 
(56) Bittner, M.; Silva, M.; Rozas, Z.; Papastergiou, F.; Jakupovic, J. Phytochemistry 1994, 36, 695. 
(57) Itokawa, H.; Watanabe, K.; Mihashi, S.; Iitaka, Y. Chem. Lett. 1984, 451. 
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compound 3.16 by hydrogenation of the exocyclic olefin at C4 and elimination of the 
primary alcohol at C10.  Compound 3.16 would act as a common intermediate and 
provide access to pleocarpenene (3.3) and pleocarpenone (3.4).  From 3.16, installation of 
the tertiary alcohol at C4 could be achieved by epoxidation of the existing terminal olefin 
and hydride reduction of the intermediate oxirane.  The terminal olefin at C10 of 
pleocarpenene could be installed from compound 3.16 by elimination of the primary 
alcohol.  With pleocarpenene in hand, we can access pleocarpenone by an established 
ozonolysis/epimerization sequence.50  Compound 3.16 will be generated by thermal 
fragmentation of cyclopropane 3.17.   
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Cyclopropane 3.17 will be derived from cyclobutene 3.18 by employing our copper 
catalyzed, EDA-mediated cyclopropanation.   Cyclobutene 3.18 will be accessed from 
iron complex 3.19 through a cyclobutadiene cycloaddition.  Through this planned 
synthesis five guaiane natural products will be generated from a common cyclopropane 
(3.17) and 5-7 ring system intermediate (3.16).   
3.4 Synthesis of cyclopropane 3.17 
 The synthesis of cyclopropane 3.17 begins with generation of iron methyl ester 
3.21 from commercially available pyrone 3.20 (Scheme 3.3). UV irradiation of pyrone 
3.20, followed by treatment with diironnonacarbonyl provides iron methyl ester 3.21.  
Reduction of the methyl ester in 3.21 with DIBAL-H provides a primary alcohol, which 
is then oxidized to afford iron aldehyde in 79% yield over two steps.  Alkylation of this 
aldehyde with but-3-enylmagnesium bromide provides iron alcohol in 3.22 in 96% yield.  
Oxidation of alcohol 3.22 to the ketone, followed by a CBS reduction generates a chiral 
iron alcohol in 96% yield and 92% ee.58  The stereogenic center generated from this 
reduction is used to set the remaining stereocenters found in the target natural products.  
Cross metathesis catalyzed by the Hoveyda-Grubbs second-generation catalyst (3.24) and 
performed between methyl acrylate and the terminal olefin of our chiral iron alcohol 
proceeds in 94% yield to afford iron complex 3.25.59  Oxidation of iron complex 3.25 
                                                
(58) For examples of CBS reductions of transition metal π-complexes of achiral ketones see (a) Corey, E. 
J.; Helal, C. J. Tetrahedron Lett. 1996, 37, 4837-4840, (b) Schwing, L.; Knochel, P. Tetrahedron Lett. 
1996, 37, 25-28, (c) Corey, E. J.; Helal, C. J. Tetrahedron Lett. 1995, 36, 9153-9156. 
(59) (a) Chatterjee, A. K.; Choi, T.; Sander, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 11360-
11370; (b) Choi, T.; Lee, C. W.; Chatterjee, A. K.; Grubbs, R. H. J. Am. Chem. Soc. 2001, 123, 10417-
10418; (c) Chatterjee, A. K.; Morgan, J. P.; Scholl, M.; Grubbs, R. H. J. Am. Chem. Soc. 2000, 122, 3783-
3784; (d) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168-
8179;  
 165 
using CAN induces a [4 + 2] cycloaddition between cyclobutadiene and the tethered 
olefin and affords cyclobutenes 3.26 in 3.3:1 ratio of diastereomers.   
O
O
MeO2C Fe(CO)3
CO2Me
(OC)3Fe
HO
(OC)3Fe
HO
MeO2CH CO2Me
HO
H CO2Me
HO
H
a b-d
e-g
h
+
Scheme 3.3: Synthesis of enantioenriched cyclobutenesa
a(a) h!, PhH; Fe2(CO)9, (64%); (b) DIBAL, Et2O, 0 oC to rt, (95%); (c)MnO2, CH2Cl2, (83%); 
(d) CH2=CHCH2CH2MgBr, Et2O, -78 
oC, (96%); (e) MnO2, CH2Cl2, 4 Å MS, (90%); (f) 
catechol borane, 3.23 (15 mol %), -78 oC,(96% yield, 92% ee); (g) CH2=CHCO2Me (10 equiv), 
3.24 (2.5 mol %), neat, 65 oC, (94%, 13:1 E:Z); (h) CAN, acetone, (91%, 3.3:1 ":#).
3.20 3.21
3.22
3.253.26"3.26#
N B
O
Me
H
Ph Ph
3.23
3.24
N N MesMes
Ru
O
Cl
Cl
Me Me
 
 Separation of cyclobutene diastereomers 3.26 is achieved using silver 
impregnated silica gel.  Once separated, 3.26β  provides material for synthesis of one 
enantiomer of the natural products.  Cyclobutene 3.26α  can be recycled using an efficient 
Mitsunobu/hydrolysis procedure to provide material for synthesis of the opposite 
enantiomer of the natural products (eq. 3.1).60 
                                                                                                                                            
(e) Kingsbury, J. S.; Harrity, J. P. A.; Bonitatebus, P. J., Jr.; Hoveyda, A. H. J. Am. Chem. Soc. 1999, 121, 
791-799. 
(60) (a) Dembinski, R. Eur. J. Org. Chem. 2004, 2763-2772; (b) Hughes, D. L. Org. Prep. Proced. Int. 
1996, 28, 127-164; (c) Martin, S. F.; Dodge, J. A. Tetrahedron Lett. 1991, 32, 3017-3020. 
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H
CO2Me
HO
H
3.26!
a,b
H
CO2Me
HO
H
(+)-3.26"
(a) p-NO2-PhCO2H, DEAD, PPh3, 0 oC to r.t., 83% yield; 
(b) NaOMe, MeOH, 95% yield.
(eq. 3.1)
 
 With cyclobutene 3.26β  in hand, we reduce the methyl ester using LAH to obtain 
the primary alcohol (Scheme 3.4).  One-pot bis-protection of this cyclobutene diol using 
triisopropylsilyl chloride and acetic anhydride provides cyclobutene 3.27 in 89% yield 
over two steps.  Protection of the alcohols is necessary in order to avoid competitive O-H 
insertion during the cyclopropanation reaction.61  Treatment of cyclobutene 3.27 with our 
optimized cyclopropanation conditions, followed by exposure to sodium ethoxide to 
remove the acetate group, generates cyclopropane 3.28 in 95% yield and >20:1 
diastereoselectivity.  Bis-alkylation of the ethyl ester installs the tertiary alcohol moiety 
observed in the target natural products and affords cyclopropane diol 3.17 in 82% yield. 
                                                
(61) Doyle, M. P.; McKervey, M. A.; Ye, T. Modern Catalytic Methods for Organic Synthesis with Diazo 
Compounds: From Cyclopropanes to Ylides. Wiley: New York, NY; 1998. 
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Scheme 3.4: Synthesis of cyclopropane 3.17a
H CO2Me
HO AcO
OTIPS
H
HO
HO
OTIPS
H H
HO
OTIPS
EtO2C
i
j
k
a(i) 1) LAH, THF, 0 oC to rt,; 2) TIPSCl, DMAP, Et3N, THF, 4 Å MS;
Ac2O (89% over 2 steps); (j) EDA, Cu(acac)2 (5 mol %), CH2Cl2, reflux;
EtOH, rt; then NaOEt(s) (95%); (k) MeMgCl, THF, -78 
oC to rt, (82%).
3.26! 3.27
3.283.17
 
3.5-Themal fragmentation and functionalization of the 5-7 ring system 
 Thermal fragmentation of cyclopropane 3.17 at 200 oC proceeds in 95% yield to 
afford cycloheptadiene 3.29 with stereochemical inversion at C1 (eq. 3.2).  
H
HO
OTIPS
HO
HO
HO
H
OTIPS
200 oC
3.17 3.29
1 1
PhH, BHT
95%
(eq. 3.2)H
 
With the 5-7 ring skeleton complete, our next goal became the reduction of both olefins 
by hydrogenation.  We desired the reduced product with cis stereochemistry at the ring 
juncture and believed this could be achieved by substrate control.  Prior to hydrogenation, 
the secondary alcohol was protected as a TBS-ether (eq. 3.3). 
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HO
HO
H
OTIPS
3.29
TBSCl, imid.
CH2Cl2
99%
TBSO
HO
H
OTIPS
3.30
(eq. 3.3)
 
Initial hydrogenation screens performed with Pt/C as a catalyst provided complex 
mixtures resulting from desired hydrogenation (3.31), hydrogenolysis of the silyl ether 
(3.32), and isomerization of the tri-substituted olefin to form a tetra-substituted olefin 
(3.33) (Table 3.1).  The best results with Pt/C as a catalyst were obtained using ethyl 
acetate as a solvent under 1 atm of hydrogen (entry 1).  Evaluating the reaction using 
other solvents did not provide any improvement (entry 2-7), and increasing hydrogen 
pressure led to increased amounts of hydrogenolysis product 3.32. 
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TBSO
HO
H
OTIPS
Pt/C
solvent 
[0.05 M] 
H2, 15 h TBSO
HO
H
OTIPS
HO
H
OTIPS
TBSO
HO
OTIPS
++
3.31 3.32 3.333.30
HH
Entrya
1
2
3
4
5
6
7
8
9
10
Pressure
1 atm
1 atm
1 atm
1 atm
1 atm
1 atm
1 atm
10 atm
10 atm
10 atm
Solvent
EtOAc
acetone
IPA
THF
DCE
CHCl3
PhMe
EtOAc
THF
IPA
Major Product(s)b
3.31:3.32 (2:1)
3.31:3.32 (1:1)
3.31:3.32 (1:1)
3.31:3.33 (1:1)
3.32
3.32
3.32
3.32
3.32
3.32
a catalyst loading was based on 10 mg of substrate/10 mg catalyst in 
0.5 mL of solvent; b Ratios were determined by 1H-NMR.
Table 3.1:  Hydrogenations of 3.30 catalyzed with platinum on carbon
 
Based on these results we chose to abandon Pt/C and investigate Raney Nickel as the 
catalyst.  Screening Raney Nickel 2800 under 1 atm of hydrogen with various solvents 
showed that ethyl acetate once again provided the best result (entry 1, Table 3.2).  Under 
these conditions, the hydrogenation in ethyl acetate provided only desired product (3.31) 
and isomerized product (3.33), while other solvents showed competitive amounts of 
hydrogenolysis product (3.32) (entries 2-4). 
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TBSO
HO
H
OTIPS
RaNi
2800
solvent 
[0.05 M] 
H2, 15 h TBSO
HO
H
OTIPS
HO
H
OTIPS
TBSO
HO
OTIPS
++
3.31 3.32 3.333.30
HH
Entrya
1
2
3
4
Pressure
1 atm
1 atm
1 atm
1 atm
Solvent
EtOAc
acetone
IPA
THF
Major Product(s)b
3.31:3.33 (1:1)
3.31:3.32:3.33 (1:1:1)
3.31:3.32 (1:1)
3.32:3.33 (1:1)
a catalyst loading was based 10 mg of substrate/1 mL catalyst in 0.5 mL of 
solvent; b Ratios were determined by 1H-NMR.
Table 3.2:  Hydrogenations of 3.30 catalyzed with Raney Nickel 2800
 
Following the lead provided by the result with Raney Nickel 2800 in ethyl acetate, we 
investigated the effects of increased hydrogen pressure on the reaction outcome.  
Increasing the hydrogen pressure to 100 atm afforded the desired product 3.31 with no 
observable isomerization product 3.33.  Treatment of 3.31 with TBAF removed both silyl 
protecting groups and generated triol 3.34 in 73% yield over two steps (eq. 3.4).   
TBSO
HO
H
OTIPS
(i) W. R. Grace
Raney-Ni 2800
EtOAc, H2 (100 atm)
HO
HO
H
OH
3.343.30
H
(eq. 3.4)
(ii) TBAF, THF
73%
 
Further transformations required a protecting group on the primary alcohol, and  
attempts to protect the primary alcohol as a triisopropylsilyl ether met with resistance in 
the form of competitive protection of the secondary alcohol.  Fortunately, further 
investigation of the hydrogenation reaction showed it was not necessary to protect the 
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secondary alcohol.  Treating diol 3.29 with Raney Nickel 2800 in ethyl acetate under 100 
atm of hydrogen provided the fully saturated diol 3.35 in 73% yield (eq. 3.5). 
HO
HO
H
OTIPS
 W. R. Grace
Raney-Ni 2800
HO
HO
H
OTIPS
3.353.29
H
(eq. 3.5)
EtOAc, H2 (100 atm)
73%
 
With a more efficient hydrogenation process developed, the synthesis progresses 
to intermediate 3.16 by oxidation of the secondary alcohol with PCC, followed by 
olefination of the ketone using Tebbe’s reagent (eq. 3.6).62  Compound 3.16 represents 
the final intermediate that is common to the syntheses of all five natural products. 
HO
H
OTIPS
H
3.16
(ii)Tebbe's reagent
pyr, THF
-42 oC to r.t.
80% conv, 94% yield
(i) PCC, CH2Cl2
88%
HO
HO
H
OTIPS
3.35
H
(eq. 3.6)
 
3.6-Completion of the natural products 
 Progressing intermediate 3.16 toward the completion of pleocarpenene and 
pleocarpenone requires installation of a tertiary alcohol at C4.  This is achieved using m-
CPBA to oxidize the olefin to an epoxide, which is then reduced to a tertiary alcohol with 
LAH.  Removal of the triisopropylsilyl ether using TBAF affords triol 3.36, a key 
intermediate in our previous synthesis of pleocarpenene and pleocarpenone, in 61% yield 
                                                
(62) (a) Cannizzo, L. F.; Grubbs, R. H. J. Org. Chem. 1985, 50, 2386-2387; (b) Clawson, L.; Buchwald, S. 
L.; Grubbs, R. H. Tetrahedron Lett. 1984, 25, 5733-5736; (c) Pine, S. H.; Pettit, R. J.; Geib, G. D.; Cruz, S. 
G.; Gallego, C. H.; Tijerina, T.; Pine, R. D. J. Org. Chem. 1985, 50, 1212-1216. 
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over three steps (Scheme 3.5). The synthesis of pleocarpenene can be completed using 
the reported elimination procedure, while pleocarpenone can be constructed from 
pleocarpenene using the reported ozonolysis/epimerization procedure.50 
H
HOH
Me
Me
OTIPS
3.16
HO Me
H
HOH
Me
Me
OH
3.36
Me
Me
OH
HO Me
H
 pleocarpenene (3.3)
Scheme 3.5: Completion of the synthesis of pleocarpenene (3.3)
H1) m-CPBA, CH2Cl2
2) LAH, Et2O
0 °C to r.t.
3)TBAF
61% yield
over three steps
10
4
7
10
4
7
10
4
7
 
 The approach to the other three natural products requires a stereoselective 
hydrogenation to install a methyl group at C4 with β configuration.  A number of 
different catalysts were evaluated for the desired hydrogenation with compound 3.16 and 
the results appear in Table 3.3.  Both homogeneous and heterogeneous catalysts were 
screened with 1 atm hydrogen, and the best result was obtained with Rh/C in EtOH (entry 
12), which afforded a diastereoselectivity of 5.3:1 (β:α).   
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H
HOH
OTIPS
H
HHO
OTIPS
Entrya
1
2
3
4
5
6
7
8
9
10
11
12
Catalyst
RhCl(PPh3)3
RhCl(PPh3)3
Pd/C (10 wt%)
Pd/C (10 wt%)
Pd/alumina (5 wt%)
Pd/alumina (5 wt%)
Pt/C (10 wt%)
Pt/C (10 wt%)
PtO2
PtO2
Rh/C (5 wt%)
Rh/C (5 wt%)
Solvent
PhH
EtOH
EtOAc
EtOH
EtOAc
EtOH
EtOAc
EtOH
EtOAc
EtOH
EtOAc
EtOH
Ratio !:"b
2.7:1c
3.2:1
n.d.d
1.2:1
1.8:1
1.5:1
0.9:1
1.9:1
1.5:1
2.1:1
4.2:1
5.3:1
catalyst, solvent
1 atm H2, 15 h
a catalyst loading was based 2mg of substrate/2mg catalyst in 0.5 mL of solvent; b Ratios were determined
by GC and/or 1H-NMR analysis; c Reaction carried out on 0.04 mmol substrate (0.04 M) and 20 mol% 
catalyst loading;  d complete decomposition was observed
Table 3.3:  Results for hydrogenation of compound 3.16
3.16 3.37
10
4
7
10
4
7
 
Unfortunately, separation of the α and β diastereomers (3.37) was not feasible, 
and attempts to progress the mixture further along the synthetic sequence did not provide 
an opportunity for separation.  As a result of these separation difficulties, the discovery of 
a more diastereoselective hydrogenation became necessary.  After further hydrogenation 
screens applied to compound 3.16 did not improve the diastereoselectivity, we decided to 
investigate a new substrate.  Deprotection of the triisopropylsilyl ether of 3.16 with 
TBAF provided a new substrate for screening, diol 3.38 (eq. 3.7). 
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HO
H
OTIPS
H
3.16
TBAF, THF
94%
HO
H
OH
H
3.38
(eq. 3.7)
 
Initial hydrogenation screening with compound 3.38 was performed using both 
Raney Nickel 2800 and Wilkinson’s catalyst under 65 atm of hydrogen (Table 3.4).  
While hydrogenation using Wilkinson’s catalyst provided both α and β diastereomers 
(entries 1 & 2), hydrogenation using Raney Nickel 2800 provided only the desired β 
diastereomer (entries 3 & 4). Upon optimization, the best results were achieved using 
ethyl acetate as a solvent under 1 atm of hydrogen (Scheme 3.5). 
H
HOH
OH
H
HHO
OH
Entrya
1
2
3
4
Catalyst
RhCl(PPh3)3
RhCl(PPh3)3
RaNi 2800
RaNi 2800
Solvent
PhH
EtOH
PhH
EtOH
Ratio !:"b
3.5:1
3.2:1
1:0
1:0
catalyst, solvent
65 atm H2, 15 h
a catalyst loading was based 2mg of substrate/2mg catalyst in 0.5 mL of solvent; b Ratios were determined
 1H-NMR analysis
Table 3.4:  Results for hydrogenation of compound 3.38
3.38 3.39
10
4
7
10
4
7
 
With the desired methyl group in place at C4, the terminal olefin at C10 was 
constructed beginning with tosylation of the primary alcohol to afford compound 3.40.  
Elimination of the primary tosylate proceeds upon treatment with sodium iodide and 
DBU to afford terminal olefin 3.15 in 76% yield. 
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Scheme 3.5:  Synthesis of terminal olefin 3.15a
HO
H
OH
H
a
HO
H
OH
H
b
HO
H
H
a(a) W.R. Grace 2800 RaNi, H2 (1 atm), EtOAc, (89%); (b) TsCl, 
Et3N, DMAP, CH2Cl2, (99%); (c) NaI, DBU, DMF, 80 
oC, (76%).
3.38
3.39
3.15
HO
H
OTs
H
3.40
c
10
4
7
10
4
7
10
4
7
10
4
7
 
Terminal olefin 3.15 acts as a key intermediate used to access 11-
hydroxypogostol (3.11), bulnesol (3.6), and hanamyol (3.7).  From compound 3.15, 
synthesis of the C10 tertiary alcohol of 11-hydroxypogostol (3.11) begins with an m-
CPBA facilitated epoxidation (eq. 3.8).  Immediate reduction of the intermediate epoxide 
using LAH affords a 1.5:1 mixture of 11-hydroxypogostol (3.11) and its C10 epimer 
(3.41).  These diastereomers are readily separable by silica gel chromatography and upon 
purification 11-hydroxypogostol (3.11) is isolated in 48% yield over two steps, while 
diastereomer 3.41 is isolated in 30% yield. 
HO
H
H
(i) m-CPBA, NaHCO3
CH2Cl2
(ii) LAH, Et2O
HO
H
H
HO
11-hydroxypogostol (3.11)
48%
+
HO
H
H
OH
30%
3.413.15
(eq. 3.8)
10
4
7
10
4
7
10
4
7
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Generation of bulnesol (3.6) from intermediate 3.15 occurs in 82% yield using a 
RhCl3⋅H2O catalyzed olefin isomerization (eq. 3.9).63  The success of this reaction 
depends on the presence of K2CO3 to neutralize any HCl generated from the catalyst.  
Reactions run in the absence of K2CO3 suffered from low yields and mass recovery.  
HO
H
H
RhCl3•H2O 
K2CO3
EtOH, reflux
82% HO H
bulnesol (3.6)
(eq. 3.9)
3.15  
Epoxidation of bulnesol (3.6) using m-CPBA, followed by treatment with TFA, 
which promotes epoxide opening by the tertiary alcohol, generates hanamyol (3.7) in 
28% yield over two steps. (eq. 3.10).64 
HO H
bulnesol (3.6)
(i)m-CPBA, NaHCO3
CH2Cl2
H
OH
O
hanamyol (3.7)
(ii) TFA, EtOH
29% over 2 steps
(eq. 3.10)
 
3.7-Conclusion 
 The cyclopropanation-thermal fragmentation strategy previously developed in our 
group has been showcased as a common platform for the synthesis of guaiane natural 
products.  Five guaiane natural products were synthesized from one divergent synthetic 
strategy.  The varied functionality and stereochemistry of these five natural products 
                                                
(63) Andrieux, J.; Barton, D. H. R., Patin, H. J. C. S. Perkin 1 1977, 359-363. 
(64) Siwicka, A.; Cuperly, D.; Tedeschi, L.; Vézouët, R. L.; White, A. J. P.; Barrett, A. G. M. Tetrahedron 
2007, 63, 5903-5917. 
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highlights the ability of our methodology to provide a robust pathway to access many 
desired guaiane natural products.    
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3.8 Experimental section 
General Information 
 For general information see Chapter 2. 
Experimental Procedures65 
HO
H
OTIPS
H
3.16
TBAF, THF
94%
HO
H
OH
H
3.38  
A round bottom flask (25 mL) was charged with compound 3.1665 (122 mg, 0.309 
mmol) in THF (3.0 mL) and TBAF (0.93 mL, 0.927 mmol of a 1.0 M solution in THF).  
The flask was flushed with N2, and the reaction was stirred at room temperature (rt).  The 
consumption of starting material was monitored by TLC.  Upon completion (12 h), the 
reaction was quenched by the addition of saturated NH4Cl(aq) (7 mL) and Et2O (10 mL)  
The two layers were separated and the aqueous layer was extracted with Et2O (3 X 15 
mL).  The combined organic extracts were washed with brine (10 mL), dried over 
MgSO4, filtered, and concentrated in vacuo.  The reaction mixture was purified by silica 
gel chromatography (100% CH2Cl2 with a gradient to 1:1 CH2Cl2:Et2O) to afford diol 
3.38 (69 mg, 0.29 mmol, 94% yield) as a white solid. 
Compound 3.38: mp = 90-92 oC.   [α]20D:  +26o (c = 1.5, MeOH).  1H-NMR (400 
MHz, CDCl3): δ 4.87 (d, J = 20.0 Hz, 2H), 3.45 (qd, J = 7.5, 10.3 Hz, 2H), 2.46-2.39 (m, 
                                                
(65) For experimental procedures for compounds 3.16-3.36 see: Williams, M. J.  The Development of New 
Methods Toward Guaiane Natural Products.  Ph.D. Dissertation, Boston College, Chestnut Hill, MA, 2007. 
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2H), 2.31-2.17 (m, 2H), 1.98-1.91 (m, 1H), 1.77-1.51 (m,  5H), 1.45-0.96 (m, 6H), 1.18 
(s, 3H), 1.14 (s, 3H).  13C-NMR (100 MHz, CDCl3): δ 157.9, 105.4, 74.1, 67.3, 50.5, 
47.6, 44.2, 40.5, 32.8, 31.1, 27.9, 27.7, 25.5, 23.6, 22.1.  IR (KBr pellet):  3396 (s), 3062 
(w), 2948 (s), 2863 (m), 2357 (w), 2328 (w), 1650 (m), 1467 (m), 1434 (m), 1382 (m), 
1166 (m), 1132 (m), 1100 (m), 1065 (m), 1018 (m), 876 (m), 678 (m) cm-1.  HRMS 
(m/z):  Calcd for C15H27O2 (M + H):  239.20110; Found: 239.20113.  
HO
H
OH
H
HO
H
OH
H
3.38
3.39
W. R. Grace
Raney Ni
2800
H2 (1atm)
EtOAC
89%  
In a  pear shaped flask (25 mL) was placed 7 cm3 of wet (water) W. R. Grace 
Raney Nickel 2800 (measured from a 1 cm3 spoon).  The water was removed by 
decantation until the solvent layer was just above the top of the catalyst.  The catalyst was 
washed with acetone (3 X 10 mL) and then ethyl acetate (3 X 10 mL).  After the final 
wash, a solution of compound 3.38 (47.0 mg, 0.197 mmol) in ethyl acetate (12 mL, 
0.016M) was added to the catalyst.  The flask was then equipped with a Teflon septum 
and flushed with H2 for 30 seconds.  The reaction was allowed to stir at rt under a balloon 
of H2.  After 6 h, the balloon was removed, and the reaction was filtered through Celite 
atop of silica gel with MeOH:EtOAc (1:9, 50 mL).  The filtrate was concentrated, and the 
reaction mixture was purified by silica gel chromatography (100% CH2Cl2 with a 
gradient to 1:1 CH2Cl2:Et2O) to afford compound 3.39 (42.4 mg, 0.176 mmol, 89% yield) 
as a white solid. 
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Compound 3.39: mp = 110-112 oC.  [α]20D:  +25o (c = 1.5, MeOH).  1H-NMR (400 
MHz, CDCl3): δ 3.35 (qd, J = 7.6, 10.4, 2H), 2.35-2.28 (m, 1H), 2.07-1.97 (m, 1H), 1.95-
1.90 (m, 1H), 1.77-1.63 (m, 4H), 1.59-1.42 (m, 5H), 1.39-1.33 (m, 3H), 1.24-1.10 (m, 
1H), 1.16 (s, 3H), 1.13 (s, 3H), 0.93 (d, J = 4.0 Hz, 3H), 0.91-0.79 (m, 1H).  13C-NMR 
(100 MHz, CDCl3): δ 74.4, 67.7, 50.3, 47.8, 44.2, 40.8, 38.8, 30.9, 28.0, 27.8, 25.7, 22.6, 
22.5, 21.2, 16.5.  IR (KBr pellet): 3402 (s), 2951 (s), 2868 (s), 2361 (m), 2341 (m), 1633 
(w), 1471 (m), 1380 (m), 1254 (w), 1200 (w), 1178 (w), 1164 (w), 1138 (w), 1116 (w), 
1065 (w), 1037 (w), 1008 (w), 925 (w), 882 (w), 668 (w), 468 (w) cm-1.  HRMS (m/z):  
Calcd for C15H27O1 (M - H2O + H):  223.20619; Found:  223.20647. 
HO
H
OH
H
3.39
HO
H
OTs
H
3.40
TsCl, Et3N
DMAP, CH2Cl2
99%  
 A round bottom flask (25 mL) was charged with compound 3.39 (55.0 mg, 0.230 
mmol) in CH2Cl2 (4 mL), DMAP (42.0 mg, 0.340 mmol), triethyl amine (47.0 µL, 0.340 
mmol), and tosyl chloride (65.0 mg, 0.340 mmol). The flask was flushed with N2 and the 
reaction was stirred at rt.  The consumption of starting material was monitored by TLC.  
Upon completion (12 h), the reaction was quenched by the addition of saturated NH4Cl(aq) 
(3 mL), H2O (3 mL), and Et2O (10 mL). The two layers were separated, and the aqueous 
layer was extracted with Et2O (3 X 10 mL).  The combined organic extracts were washed 
with saturated NaHCO3(aq) (10 mL) and brine (10 mL), dried over MgSO4, filtered and 
concentrated in vacuo.  The reaction mixture was purified by silica gel chromatography 
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(100% CH2Cl2 with a gradient to 9:1 CH2Cl2:Et2O) to afford compound 3.40 (90.7 mg, 
0.230 mmol, 99% yield) as a white solid. 
Compound 3.40: mp = 85-85 oC .  [α]20D:  +21o (c = 1.4, CHCl3).  1H-NMR (400 
MHz, CDCl3): δ 7.75 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 3.70 (d, J = 7.6 Hz, 
2H), 2.42 (s, 3H), 2.26-2.17 (m, 1H), 2.13-2.06 (m, 1H), 1.99-1.83 (m, 1H), 1.69-1.57 
(m, 3H), 1.54-1.14 (m, 9H), 1.11 (s, 3H), 1.08 (s, 3H), 0.90 (d, J = 6.9 Hz, 3H), 0.82-0.72 
(m 1H).  13C-NMR (100 MHz, CDCl3): δ 144.7, 129.9, 128.0, 126.5, 74.5, 74.1, 49.9, 
47.5, 43.6, 38.6, 37.3, 30.7, 27.9, 27.3, 25.7, 22.5, 22.3, 21.8, 20.8, 16.3.  IR (KBr pellet) 
3484 (s), 3029 (m), 2960 (s), 2873 (s), 1474 (m), 1357 (s), 1172 (s), 1097 (m), 958 (s), 
865 (s), 825 (m), 668 (m), 554 (m) cm-1.  HRMS (m/z):  Calcd for C22H34O4NaS (M + 
Na):  417.2076; Found:  417.2068. 
HO
H
H
3.15
HO
H
OTs
H
3.40
NaI, DBU
DMF, 80 oC
76%  
 A degassed solution of compound 3.40 (262 mg, 0.664 mmol), NaI (498 mg, 3.32 
mmol), and DBU (298 µL, 1.99 mmol) in DMF (6.64 mL) in a round bottom flask (25 
mL) was placed in a silicone oil bath and heated to 80 oC.  The consumption of starting 
material was monitored by NMR analysis.  Upon completion (3 h), the reaction was 
quenched with saturated NH4Cl(aq) (10 mL) and Et2O (10 mL).  The organic layer was 
removed and the aqueous layer was extracted with Et2O (3 X 20 mL).  The combined 
organic layers were washed with H2O (3 X 15 mL) and brine (15 mL), dried over MgSO4, 
filtered, and concentrated in vacuo.  The resulting oil was purified by silica gel 
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chromatography (100% CH2Cl2) to afford compound 3.15 as a colorless oil in 76% yield 
(111 mg, 0.499 mmol). 
 Compound 3.15: [α]20D:  -3.1o (c = 1.5, CHCl3).  1H-NMR (400 MHz, 
CDCl3): δ 4.74 (d, J = 24.6 Hz, 2H), 2.75 (q, J = 8.6 Hz, 1H), 2.43-2.36 (m, 1H), 2.10-
1.90 (m, 3H), 1.84-1.61 (m, 4H), 1.38-1.20 (m, 3H), 1.16 (s, 3H), 1.13 (s, 3H), 0.93 (d, J 
= 6.9 Hz, 3H), 0.85-0.75 (m, 1H).   13C-NMR (100 MHz, CDCl3): δ 154.1, 110.1, 74.0, 
52.1, 50.3, 47.9, 39.1, 35.0, 32.6, 32.2, 28.6, 27.9, 26.5, 25.1, 16.3.  IR (NaCl thin film):  
3377 (m), 3073 (w), 2953 (s), 2867 (s), 1636 (w), 1466 (w), 1377 (m), 1173 (w), 1131 
(w), 1007 (w), 885 (m), 736 (m), 606 (m) cm-1. HRMS (m/z):  Calcd for C15H25 (M - H2O 
+ H):  205.19563; Found:  205.19649. 
HO
H
H
(i) m-CPBA, NaHCO3
CH2Cl2
(ii) LAH, Et2O
HO
H
H
HO
11-hydroxypogostol (3.11)
48%
+
HO
H
H
OH
30%
3.413.15
 
 A 2 dram vial was charged with compound 3.15 (17 mg, 76 µmol) in CH2Cl2 (1.9 
mL) and NaHCO3 (76.6 mg, 0.912 mmol).  The vial was flushed with N2 and cooled to 0 
oC in an ice bath.  The vial was charged with m-CPBA (19.8 mg, 0.115 mmol) and stirred 
at 0 oC for 10 min., after which the bath was removed and the reaction allowed to warm 
to rt.  The consumption of starting material was monitored by TLC.  Upon completion (1 
h), the reaction was quenched with saturated NaHCO3(aq) (1 mL), saturated Na2S2O3(aq) (1 
mL), and Et2O (2 mL).  The mixture was stirred for 1 h and the organic layer was 
removed.  The aqueous layer was extracted with Et2O (4 X 3 mL).  The combined organic 
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extracts were dried over Na2SO4, filtered, and concentrated in vacuo.  The resulting 
material was used in the next reaction without further purification.66 
 To a solution of the above material in Et2O (2 mL) stirring at 0 oC in an ice bath 
was added LAH (400 µL, 0.400 mmol of a 1.0 M solution in THF).  Once addition was 
complete, the ice bath was removed and the reaction warmed to rt.  The consumption of 
starting material was monitored by TLC.  Upon completion (1 h), the reaction was cooled 
to 0 oC and quenched by the slow addition of H2O (15.2 µL), 15% NaOH(aq) (15.2 µL), 
and H2O (45.6 µL).  The mixture was warmed to rt and filtered through Celite with Et2O 
(10 mL).  The resulting mixture was purified by silica gel chromatography (100% CH2Cl2 
with a gradient to 3:1 CH2Cl2:Et2O then to 100% Et2O) to afford 11-hydroxypogostol 
(3.11) (8.7 mg, 36 µmol) as a white solid. 
11-hydroxypogostol (3.11):  mp = 60-62 oC.  [α]20D:  +16o (c = 0.4, CHCl3).67 1H-
NMR (400 MHz, pyridine-d5): δ 2.39-2.32 (m, 2H), 2.30-2.22 (m, 2H), 2.14-1.97 (m, 
3H), 1.78-1.48 (m, 5H), 1.42 (s, 3H), 1.39 (s, 3H), 1.37 (s, 3H), 1.36-1.23 (m, 1H), 1.17-
1.08 (m, 1H), 1.00 (d, J = 6.9 Hz, 3H).  13C-NMR (100 MHz, pyridine-d5): δ 74.0, 73.5, 
56.9, 49.7, 48.2, 40.1, 34.9, 32.6, 31.8, 28.9, 27.1, 26.6, 26.0, 23.7, 17.2.68  IR (KBr 
pellet):  3416 (s), 3060 (m), 3028 (s), 2933 (s), 1454 (m), 1371 (m), 1218 (w), 1174 (m), 
1141 (m), 1103 (m), 752 (m), 699 (m), 539 (m), 456 (w) cm-1. HRMS (m/z):  Calcd for 
C15H27O (M - H2O + H):  223.20619; Found:  223.20664. 
    
                                                
(66) Purification of the material at this point results in lower yields. 
(67) Melting point and rotation of natural 11-hydroxypogostol not reported. 
(68) Values are reported with pyridine referenced at 150.35, 135.91, 123.87 ppm and are consistently 0.6 
ppm downfield from the reported values (ref. 55). 
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HO
H
H
RhCl3•H2O 
K2CO3
EtOH, reflux
82% HO H
bulnesol (3.6)3.15  
 A round bottom flask (10 mL) was charged with compound 3.15 (21.0 mg, 
94.4µmol) in EtOH (6 mL), K2CO3 (29.0 mg, 0.208 mmol), and RhCl3·H20 (13.0 mg, 
63.0 µmol).  The flask was equipped with a reflux condenser, flushed with N2, placed in a 
silicone oil bath and heated to reflux.  The consumption of starting material was 
monitored by NMR analysis.  Upon completion (12 h), the reaction was filtered through 
Celite atop of silica gel with Et2O (20 mL) and concentrated in vacuo.  The resulting oil 
was purified by silica gel chromatography (100% CH2Cl2) to afford bulnesol (3.6) (17.2 
mg, 77.3 µmol) as a colorless oil. 
Bulnesol (3.6):  [α]20D:  +10o (c = 1.4, CHCl3).69 1H-NMR (400 MHz, CDCl3): δ 
2.41-2.28 (m, 2H), 2.20-2.03 (m, 4H), 1.92-1.82 (2H), 1.69-1.63 (m, 1H), 1.65 (br s, 3H), 
1.16 (s, 6H), 1.13-0.92 (m, 3H), 0.89 (d, J = 7.0 Hz, 3H), 0.86-0.73 (m, 1H).  13C-NMR 
(100 MHz, CDCl3): δ 141.8, 129.0, 74.0, 54.3, 46.5, 39.3, 35.1, 33.3, 30.6, 29.0, 28.0, 
27.5, 27.4, 22.6, 15.6.70  IR (NaCl thin film):  3399 (s), 3027 (m), 2934 (m), 2919 (s), 
2868 (m), 1464 (w), 1378 (m), 1166 (w), 1135 (m),  1095 (w), 704 (w) cm-1. HRMS 
(m/z):  Calcd for C15H25 (M - H2O + H):  205.19563; Found:  205.19584. 
    
                                                
(69) Rotation of natural bulnesol is reported as [α]20D:  +3.8o (c = 7.8, EtOH).  Dolejs, L.; Mironov, A.; 
Sorm, F. Collection Czechoslov. Chem. Commun. 1961, 26, 1015-1020. 
(70) 1H-NMR and 13C-NMR match reported values for natural bulnesol.  Raharivelomanana, P.; Bianchini, 
J. P.; Cambon, A.; Azzaro, M. Magn. Reson. Chem. 1995, 33, 233-235. 
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HO H
bulnesol (3.6)
(i)m-CPBA, NaHCO3
CH2Cl2
H
OH
O
hanamyol (3.7)
(ii) TFA, EtOH
29% over 2 steps
 
 A 2 dram vial was charged with bulnesol (3.6) (10 mg, 45 µmol) in CH2Cl2 (1.1 
mL) and NaHCO3 (45 mg, 0.54 mmol).  The vial was flushed with N2 and cooled to 0 oC 
in an ice bath.  The vial was charged with m-CPBA (11.6 mg, 67.7 µmol) and stirred at 0 
oC for 10 min., after which the bath was removed and the reaction warmed to rt.  The 
consumption of starting material was monitored by TLC.  Upon completion (1 h), the 
reaction was quenched with saturated NaHCO3(aq) (1 mL), saturated Na2S2O3(aq) (1 mL), 
and Et2O (2 mL).  The mixture was stirred for 1 h and the organic layer was removed.  
The aqueous layer was extracted with Et2O (4 X 3 mL).  The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated in vacuo.  The resulting material was 
used in the next reaction without further purification. 
 The above material was dissolved in an 18 mM solution of TFA in EtOH (500 
µL) in a 2 dram vial.  The reaction was stirred at rt and the consumption of starting 
material was monitored by NMR analysis.  Upon completion (6 h), the reaction was 
quenched with saturated NaHCO3(aq) (1 mL) and Et2O (3 mL).  The organic layer was 
removed and the aqueous layer was extracted with Et2O (4 X 2 mL).  The combined 
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo.  The 
reaction mixture was purified by silica gel chromatography (100% CH2Cl2 with a 
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gradient to 3:1 CH2Cl2:Et2O) to afford hanamyol (3.7) (3.0 mg, 13 µmol, 29% yield) as 
colorless needles. 
Hanamyol (3.7):  [α]20D:  +20o (c = 0.1, CHCl3).71  1H-NMR (400 MHz, CDCl3): 
δ 2.64-2.44 (m, 1H), 2.11-2.04 (m, 1H), 1.99-1.76 (m, 4H), 1.73-1.59 (m, 3H), 1.53-0.91 
(m, 5H) 1.29 (s, 3H), 1.19 (s, 3H), 1.10 (s, 3H), 0.95 (d, J = 7.0 Hz, 3H).  13C-NMR (100 
MHz, CDCl3): δ 90.9, 75.9, 73.9, 48.2, 36.7, 35.7, 32.6, 29.8, 29.6, 29.4, 27.0, 26.5, 24.7, 
19.5, 15.4. IR (NaCl thin film):  3708 (w), 3418 (s), 2956 (s), 2900 (m), 2291 (m), 1462 
(w), 1378 (m), 1234 (w), 1127 (m), 1098 (m), 1028 (m), 1012 (m), 826 (w), 754 (w), 704 
(w), 531 (w) cm-1.  HRMS (m/z):  Calcd for C15H25O (M - H2O + H):  221.19054; Found:  
221.19063. 
    
                                                
(71) Rotation of natural hanamyol is reported as [α]15D:  -18.0o (c = 0.5, CHCl3).  1H-NMR and 13C-NMR 
match reported values for natural hanamyol. Itokawa, H.; Morita, H.; Watanabe, K.; Takase, A.; Iitaka, Y. 
Chem. Lett. 1984, 1687. 
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